Drug information for ALIMTA

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
INJECTABLE; INJECTION 500MG Prescription   PEMETREXED pemetrexed LILLY 21677
2006-06-08 Review

2005-04-15 Other Important Information from FDA

2004-08-25 Letter

2004-08-19 Label
INJECTABLE; IV (INFUSION) EQ 100MG BASE/VIAL Prescription  (Reference Drug) PEMETREXED DISODIUM pemetrexed LILLY 21462
2011-11-25 Label

2011-11-25 Label

2011-11-23 Label

2011-11-22 Letter

2011-11-22 Letter

2011-11-22 Letter

2011-09-22 Review

2011-03-23 Letter

2011-03-21 Label

2009-07-09 Label

2009-07-09 Label

2009-07-08 Letter

2009-07-08 Letter

2009-07-08 Letter

2009-07-06 Label

2008-10-01 Letter

2008-09-26 Label

2007-09-11 Letter

2007-09-11 Label

2007-02-21 Label

2007-02-12 Letter

2006-08-04 Letter

2006-08-04 Label

2005-04-15 Other Important Information from FDA

2004-08-25 Letter

2004-08-19 Label

2004-03-28 Review

2004-02-05 Letter

2004-02-05 Other

2004-02-05 Patient Package Insert

2004-02-05 Label
INJECTABLE; IV (INFUSION) EQ 500MG BASE/VIAL Prescription  (Reference Drug) PEMETREXED DISODIUM pemetrexed LILLY   "

Drug Adverse Effects information for ALIMTA

Role code Indications Reaction # Reports
PS ADENOCARCINOMA DEATH 1
PS ADENOCARCINOMA HYPOTHYROIDISM 1
PS ADENOCARCINOMA NEUTROPENIC SEPSIS 1
PS ADJUVANT THERAPY GENERALISED ERYTHEMA 1
PS ADJUVANT THERAPY HAEMATEMESIS 1
PS ANTIEMETIC SUPPORTIVE CARE GENERALISED ERYTHEMA 1
PS ANTIEMETIC SUPPORTIVE CARE HAEMATEMESIS 1
PS ANXIETY CANDIDIASIS 1
PS ANXIETY DIARRHOEA 1
PS ANXIETY ESCHERICHIA INFECTION 1
PS ANXIETY GASTROINTESTINAL NECROSIS 1
PS ANXIETY GENERAL PHYSICAL HEALTH DETERIORATION 1
PS ANXIETY HEPATIC CIRRHOSIS 1
PS ANXIETY HEPATORENAL SYNDROME 1
PS ANXIETY HYPERKALAEMIA 1
PS ANXIETY INTUSSUSCEPTION 1
PS ANXIETY LUNG DISORDER 1
PS ANXIETY PANCYTOPENIA 1
PS APPETITE DISORDER ALANINE AMINOTRANSFERASE INCREASED 1
PS APPETITE DISORDER ASPARTATE AMINOTRANSFERASE INCREASED 1
PS APPETITE DISORDER BLOOD ALKALINE PHOSPHATASE INCREASED 1
PS APPETITE DISORDER FATIGUE 1
PS ARTERIOSCLEROSIS OBLITERANS BONE MARROW FAILURE 3
PS ARTERIOSCLEROSIS OBLITERANS INTERSTITIAL LUNG DISEASE 3
PS ARTERIOSCLEROSIS OBLITERANS RASH 3
PS BACK PAIN ANAPHYLACTIC REACTION 1
PS BENIGN PROSTATIC HYPERPLASIA CHOLECYSTITIS CHRONIC 1
PS BENIGN PROSTATIC HYPERPLASIA LUNG DISORDER 1
PS BENIGN PROSTATIC HYPERPLASIA PYELONEPHRITIS 1
PS BILE DUCT STONE PERIPHERAL EMBOLISM 1
PS BILE DUCT STONE PNEUMONITIS 1
PS BLOOD PRESSURE ABDOMINAL PAIN 2
PS BLOOD PRESSURE ACIDOSIS 1
PS BLOOD PRESSURE ATRIAL FIBRILLATION 2
PS BLOOD PRESSURE CARDIAC ARREST 2
PS BLOOD PRESSURE DIARRHOEA 2
PS BLOOD PRESSURE HYPOTENSION 1
PS BLOOD PRESSURE PANCYTOPENIA 2
PS BLOOD PRESSURE RESPIRATORY FAILURE 1
PS BLOOD PRESSURE VENTRICULAR ARRHYTHMIA 2
PS BRONCHIAL CARCINOMA ABDOMINAL DISCOMFORT 1
PS BRONCHIAL CARCINOMA AGGRESSION 1
PS BRONCHIAL CARCINOMA AKINESIA 3
PS BRONCHIAL CARCINOMA ALOPECIA 1
PS BRONCHIAL CARCINOMA ARTERIOSCLEROSIS CORONARY ARTERY 3
PS BRONCHIAL CARCINOMA BLOOD COUNT ABNORMAL 1
PS BRONCHIAL CARCINOMA BLOOD URIC ACID INCREASED 1
PS BRONCHIAL CARCINOMA COUGH 1
PS BRONCHIAL CARCINOMA DIZZINESS 1
PS BRONCHIAL CARCINOMA DYSPNOEA 1
PS BRONCHIAL CARCINOMA ERYTHEMA 1
PS BRONCHIAL CARCINOMA FATIGUE 1
PS BRONCHIAL CARCINOMA HYPERHIDROSIS 1
PS BRONCHIAL CARCINOMA MUSCULAR WEAKNESS 1
PS BRONCHIAL CARCINOMA MYOCARDIAL INFARCTION 3
PS BRONCHIAL CARCINOMA NAUSEA 1
PS BRONCHIAL CARCINOMA NEOPLASM PROGRESSION 1
PS BRONCHIAL CARCINOMA NEUROPATHY PERIPHERAL 1
PS BRONCHIAL CARCINOMA PERICARDIAL EFFUSION 3
PS BRONCHIAL CARCINOMA PLATELET COUNT DECREASED 1
PS BRONCHIAL CARCINOMA PNEUMONIA 1
PS BRONCHIAL CARCINOMA PRURITUS 1
PS BRONCHIAL CARCINOMA PULMONARY FIBROSIS 1
PS BRONCHIAL CARCINOMA RED BLOOD CELL COUNT DECREASED 1
PS BRONCHIAL CARCINOMA RENAL FAILURE 1
PS BRONCHIAL CARCINOMA SKIN DISCOLOURATION 1
PS BRONCHIAL CARCINOMA SKIN MASS 1
PS BRONCHIAL CARCINOMA STRESS CARDIOMYOPATHY 3
PS BRONCHIAL CARCINOMA THYROIDECTOMY 3
PS BRONCHIAL CARCINOMA WEIGHT FLUCTUATION 1
PS BRONCHIAL CARCINOMA WHITE BLOOD CELL COUNT DECREASED 1
PS CANCER PAIN CHOLECYSTITIS ACUTE 2
PS CANCER PAIN PLATELET COUNT DECREASED 2
PS CANCER PAIN SEPTIC SHOCK 2
PS CANCER PAIN VENOUS THROMBOSIS LIMB 2
PS CERVIX CARCINOMA ANAPHYLACTIC REACTION 1
PS CHEMOTHERAPY CARDIAC FAILURE 6
PS CHEMOTHERAPY CARDIOMYOPATHY 3
PS CHEMOTHERAPY NEOPLASM MALIGNANT 3
PS CHEMOTHERAPY RADIATION PNEUMONITIS 3
PS CHEST PAIN BACTERIAL INFECTION 1
PS CHEST PAIN LUNG DISORDER 1
PS CHEST PAIN NEUTROPHIL COUNT DECREASED 1
PS CHEST PAIN PYREXIA 1
PS CHRONIC OBSTRUCTIVE PULMONARY DISEASE ABDOMINAL ABSCESS 3
PS CHRONIC OBSTRUCTIVE PULMONARY DISEASE GASTRIC ULCER HAEMORRHAGE 3
PS CHRONIC OBSTRUCTIVE PULMONARY DISEASE PULMONARY EMBOLISM 3
PS CHRONIC OBSTRUCTIVE PULMONARY DISEASE THROMBOCYTOPENIA 3
PS CONSTIPATION CHEST PAIN 2
PS CONSTIPATION CHOLECYSTITIS CHRONIC 2
PS CONSTIPATION COUGH 2
PS CONSTIPATION INSOMNIA 2
PS CONSTIPATION LUNG DISORDER 2
PS CONSTIPATION PYELONEPHRITIS 2
PS DENTAL DISORDER PROPHYLAXIS CHOLECYSTITIS CHRONIC 1
PS DENTAL DISORDER PROPHYLAXIS LUNG DISORDER 1
PS DENTAL DISORDER PROPHYLAXIS PYELONEPHRITIS 1
PS GASTRITIS GENERALISED ERYTHEMA 1
PS GASTRITIS HAEMATEMESIS 1
PS GASTRITIS PROPHYLAXIS DIZZINESS 1
PS GASTRITIS PROPHYLAXIS DYSPHAGIA 1
PS GASTRITIS PROPHYLAXIS NAUSEA 1
PS GASTRITIS PROPHYLAXIS ODYNOPHAGIA 1
PS GASTROOESOPHAGEAL REFLUX DISEASE ALANINE AMINOTRANSFERASE INCREASED 1
PS GASTROOESOPHAGEAL REFLUX DISEASE ASPARTATE AMINOTRANSFERASE INCREASED 1
PS GASTROOESOPHAGEAL REFLUX DISEASE BLOOD ALKALINE PHOSPHATASE INCREASED 1
PS GASTROOESOPHAGEAL REFLUX DISEASE FATIGUE 1
PS HEAD AND NECK CANCER ASTHENIA 3
PS HEAD AND NECK CANCER CHILLS 3
PS HEAD AND NECK CANCER DEHYDRATION 3
PS HEAD AND NECK CANCER DIZZINESS 3
PS HEAD AND NECK CANCER HYPOTENSION 3
PS HEAD AND NECK CANCER MALAISE 3
PS HEAD AND NECK CANCER OFF LABEL USE 3
PS HEAD AND NECK CANCER PAIN 3
PS HEAD AND NECK CANCER PRODUCTIVE COUGH 3
PS HEAD AND NECK CANCER SEPSIS 3
PS HEAD AND NECK CANCER SINUS TACHYCARDIA 3
PS HYPERTENSION ACUTE PRERENAL FAILURE 8
PS HYPERTENSION ADVERSE REACTION 4
PS HYPERTENSION ARTHRALGIA 1
PS HYPERTENSION CHOLECYSTITIS ACUTE 2
PS HYPERTENSION CHOLECYSTITIS CHRONIC 2
PS HYPERTENSION DIZZINESS POSTURAL 1
PS HYPERTENSION LUNG DISORDER 2
PS HYPERTENSION METASTASES TO BONE 8
PS HYPERTENSION NEOPLASM PROGRESSION 10
PS HYPERTENSION NEPHROTIC SYNDROME 10
PS HYPERTENSION OFF LABEL USE 8
PS HYPERTENSION PERIPHERAL EMBOLISM 1
PS HYPERTENSION PLATELET COUNT DECREASED 2
PS HYPERTENSION PNEUMONITIS 1
PS HYPERTENSION PYELONEPHRITIS 2
PS HYPERTENSION SEPTIC SHOCK 2
PS HYPERTENSION VENOUS THROMBOSIS LIMB 2
PS HYPERTENSION WHITE BLOOD CELL COUNT DECREASED 2
PS HYPOAESTHESIA BACTERIAL INFECTION 1
PS HYPOAESTHESIA LUNG DISORDER 1
PS HYPOAESTHESIA NEUTROPHIL COUNT DECREASED 1
PS HYPOAESTHESIA PYREXIA 1
PS HYPOPHARYNGEAL CANCER NEOPLASM PROGRESSION 1
PS HYPOPHARYNGEAL CANCER OFF LABEL USE 1
PS HYPOPHARYNGEAL CANCER SPINAL CORD COMPRESSION 1
PS INSOMNIA ALANINE AMINOTRANSFERASE INCREASED 2
PS INSOMNIA ASPARTATE AMINOTRANSFERASE INCREASED 2
PS INSOMNIA BACTERIAL INFECTION 1
PS INSOMNIA BLOOD ALKALINE PHOSPHATASE INCREASED 2
PS INSOMNIA CHOLECYSTITIS CHRONIC 1
PS INSOMNIA FATIGUE 2
PS INSOMNIA LUNG DISORDER 2
PS INSOMNIA NEUTROPHIL COUNT DECREASED 1
PS INSOMNIA PYELONEPHRITIS 1
PS INSOMNIA PYREXIA 1
PS LARGE CELL CARCINOMA OF THE RESPIRATORY TRACT STAGE UNSPECIFIED AREFLEXIA 2
PS LARGE CELL CARCINOMA OF THE RESPIRATORY TRACT STAGE UNSPECIFIED ASTHENIA 2
PS LARGE CELL CARCINOMA OF THE RESPIRATORY TRACT STAGE UNSPECIFIED ATAXIA 2
PS LARGE CELL CARCINOMA OF THE RESPIRATORY TRACT STAGE UNSPECIFIED BULBAR PALSY 2
PS LARGE CELL CARCINOMA OF THE RESPIRATORY TRACT STAGE UNSPECIFIED DYSPHAGIA 2
PS LARGE CELL CARCINOMA OF THE RESPIRATORY TRACT STAGE UNSPECIFIED DYSPHONIA 2
PS LARGE CELL CARCINOMA OF THE RESPIRATORY TRACT STAGE UNSPECIFIED EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 6
PS LARGE CELL CARCINOMA OF THE RESPIRATORY TRACT STAGE UNSPECIFIED EYELID PTOSIS 2
PS LARGE CELL CARCINOMA OF THE RESPIRATORY TRACT STAGE UNSPECIFIED MILLER FISHER SYNDROME 6
PS LARGE CELL CARCINOMA OF THE RESPIRATORY TRACT STAGE UNSPECIFIED OPHTHALMOPLEGIA 2
PS LARGE CELL CARCINOMA OF THE RESPIRATORY TRACT STAGE UNSPECIFIED PNEUMONIA 6
PS LUNG ADENOCARCINOMA ABDOMINAL DISCOMFORT 2
PS LUNG ADENOCARCINOMA ACUTE HEPATIC FAILURE 2
PS LUNG ADENOCARCINOMA ANAEMIA 2
PS LUNG ADENOCARCINOMA ASCITES 1
PS LUNG ADENOCARCINOMA ASTHENIA 3
PS LUNG ADENOCARCINOMA ATELECTASIS 4
PS LUNG ADENOCARCINOMA ATRIAL FIBRILLATION 2
PS LUNG ADENOCARCINOMA BACTERIAL INFECTION 1
PS LUNG ADENOCARCINOMA BLOOD GLUCOSE INCREASED 2
PS LUNG ADENOCARCINOMA CARDIAC DISORDER 1
PS LUNG ADENOCARCINOMA CARDIAC FAILURE 1
PS LUNG ADENOCARCINOMA CARDIO-RESPIRATORY ARREST 2
PS LUNG ADENOCARCINOMA CEREBROVASCULAR ACCIDENT 1
PS LUNG ADENOCARCINOMA CONFUSIONAL STATE 2
PS LUNG ADENOCARCINOMA COUNTERFEIT DRUG ADMINISTERED 4
PS LUNG ADENOCARCINOMA DEATH 2
PS LUNG ADENOCARCINOMA DECREASED APPETITE 1
PS LUNG ADENOCARCINOMA DEHYDRATION 2
PS LUNG ADENOCARCINOMA DERMO-HYPODERMITIS 2
PS LUNG ADENOCARCINOMA DIARRHOEA 7
PS LUNG ADENOCARCINOMA DYSPNOEA 2
PS LUNG ADENOCARCINOMA EATING DISORDER 2
PS LUNG ADENOCARCINOMA ELECTROLYTE IMBALANCE 4
PS LUNG ADENOCARCINOMA ESCHERICHIA SEPSIS 2
PS LUNG ADENOCARCINOMA ESCHERICHIA TEST POSITIVE 2
PS LUNG ADENOCARCINOMA EXTREMITY NECROSIS 6
PS LUNG ADENOCARCINOMA FAILURE TO THRIVE 1
PS LUNG ADENOCARCINOMA FEBRILE NEUTROPENIA 2
PS LUNG ADENOCARCINOMA GENERAL PHYSICAL HEALTH DETERIORATION 2
PS LUNG ADENOCARCINOMA HAEMOLYTIC URAEMIC SYNDROME 1
PS LUNG ADENOCARCINOMA HAEMOPTYSIS 6
PS LUNG ADENOCARCINOMA HEPATIC CONGESTION 1
PS LUNG ADENOCARCINOMA HEPATOTOXICITY 1
PS LUNG ADENOCARCINOMA HYPERKALAEMIA 2
PS LUNG ADENOCARCINOMA HYPOALBUMINAEMIA 1
PS LUNG ADENOCARCINOMA HYPOCALCAEMIA 1
PS LUNG ADENOCARCINOMA ILEUS PARALYTIC 2
PS LUNG ADENOCARCINOMA INFECTIOUS PERITONITIS 1
PS LUNG ADENOCARCINOMA ISCHAEMIC STROKE 4
PS LUNG ADENOCARCINOMA LEUKOPENIA 3
PS LUNG ADENOCARCINOMA LIVER FUNCTION TEST ABNORMAL 1
PS LUNG ADENOCARCINOMA LUNG DISORDER 1
PS LUNG ADENOCARCINOMA NAUSEA 1
PS LUNG ADENOCARCINOMA NECROSIS 1
PS LUNG ADENOCARCINOMA NEOPLASM MALIGNANT 1
PS LUNG ADENOCARCINOMA NEOPLASM PROGRESSION 4
PS LUNG ADENOCARCINOMA NEUTROPENIA 1
PS LUNG ADENOCARCINOMA NEUTROPHIL COUNT DECREASED 1
PS LUNG ADENOCARCINOMA NORMOCHROMIC NORMOCYTIC ANAEMIA 1
PS LUNG ADENOCARCINOMA OXYGEN SATURATION DECREASED 2
PS LUNG ADENOCARCINOMA PALPITATIONS 4
PS LUNG ADENOCARCINOMA PANCYTOPENIA 1
PS LUNG ADENOCARCINOMA PARAESTHESIA 2
PS LUNG ADENOCARCINOMA PLEURAL EFFUSION 3
PS LUNG ADENOCARCINOMA PULMONARY OEDEMA 3
PS LUNG ADENOCARCINOMA PYREXIA 3
PS LUNG ADENOCARCINOMA RASH 1
PS LUNG ADENOCARCINOMA RASH GENERALISED 1
PS LUNG ADENOCARCINOMA RENAL FAILURE 3
PS LUNG ADENOCARCINOMA RENAL FAILURE ACUTE 1
PS LUNG ADENOCARCINOMA RENAL IMPAIRMENT 6
PS LUNG ADENOCARCINOMA RESPIRATORY FAILURE 2
PS LUNG ADENOCARCINOMA SPEECH DISORDER 2
PS LUNG ADENOCARCINOMA SWELLING 1
PS LUNG ADENOCARCINOMA TACHYCARDIA 2
PS LUNG ADENOCARCINOMA THROMBOCYTOPENIA 5
PS LUNG ADENOCARCINOMA VOMITING 3
PS LUNG ADENOCARCINOMA WEIGHT DECREASED 1
PS LUNG ADENOCARCINOMA WHITE BLOOD CELL COUNT DECREASED 4
PS LUNG ADENOCARCINOMA METASTATIC ACUTE MYOCARDIAL INFARCTION 2
PS LUNG ADENOCARCINOMA METASTATIC ANAEMIA 2
PS LUNG ADENOCARCINOMA METASTATIC BRONCHOSPASM 1
PS LUNG ADENOCARCINOMA METASTATIC CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1
PS LUNG ADENOCARCINOMA METASTATIC DEATH 2
PS LUNG ADENOCARCINOMA METASTATIC DECREASED APPETITE 2
PS LUNG ADENOCARCINOMA METASTATIC DEHYDRATION 2
PS LUNG ADENOCARCINOMA METASTATIC DIARRHOEA 2
PS LUNG ADENOCARCINOMA METASTATIC DYSPNOEA 1
PS LUNG ADENOCARCINOMA METASTATIC FEBRILE NEUTROPENIA 2
PS LUNG ADENOCARCINOMA METASTATIC MYOCARDIAL INFARCTION 1
PS LUNG ADENOCARCINOMA METASTATIC NECROSIS 1
PS LUNG ADENOCARCINOMA METASTATIC NEUTROPENIA 1
PS LUNG ADENOCARCINOMA METASTATIC RASH 3
PS LUNG ADENOCARCINOMA METASTATIC RASH ERYTHEMATOUS 2
PS LUNG ADENOCARCINOMA METASTATIC RASH PAPULAR 2
PS LUNG ADENOCARCINOMA METASTATIC SUDDEN DEATH 1
PS LUNG ADENOCARCINOMA METASTATIC THROMBOCYTOPENIA 2
PS LUNG ADENOCARCINOMA STAGE III BONE MARROW FAILURE 2
PS LUNG ADENOCARCINOMA STAGE III INTERSTITIAL LUNG DISEASE 2
PS LUNG ADENOCARCINOMA STAGE III LEUKOPENIA 6
PS LUNG ADENOCARCINOMA STAGE III ORAL CANDIDIASIS 6
PS LUNG ADENOCARCINOMA STAGE III PNEUMOMEDIASTINUM 6
PS LUNG ADENOCARCINOMA STAGE III PNEUMONIA 6
PS LUNG ADENOCARCINOMA STAGE III RASH 2
PS LUNG ADENOCARCINOMA STAGE IV ALANINE AMINOTRANSFERASE INCREASED 1
PS LUNG ADENOCARCINOMA STAGE IV ASPARTATE AMINOTRANSFERASE INCREASED 1
PS LUNG ADENOCARCINOMA STAGE IV ATRIAL FIBRILLATION 4
PS LUNG ADENOCARCINOMA STAGE IV BLOOD ALKALINE PHOSPHATASE INCREASED 1
PS LUNG ADENOCARCINOMA STAGE IV BLOOD IRON INCREASED 3
PS LUNG ADENOCARCINOMA STAGE IV BONE MARROW TUMOUR CELL INFILTRATION 2
PS LUNG ADENOCARCINOMA STAGE IV CEREBROVASCULAR ACCIDENT 4
PS LUNG ADENOCARCINOMA STAGE IV CHOLECYSTITIS ACUTE 6
PS LUNG ADENOCARCINOMA STAGE IV CHOLECYSTITIS CHRONIC 2
PS LUNG ADENOCARCINOMA STAGE IV CONFUSIONAL STATE 3
PS LUNG ADENOCARCINOMA STAGE IV DELIRIUM 3
PS LUNG ADENOCARCINOMA STAGE IV DIARRHOEA 4
PS LUNG ADENOCARCINOMA STAGE IV DYSARTHRIA 4
PS LUNG ADENOCARCINOMA STAGE IV FATIGUE 1
PS LUNG ADENOCARCINOMA STAGE IV HEMIANOPIA 4
PS LUNG ADENOCARCINOMA STAGE IV HEMIPLEGIA 4
PS LUNG ADENOCARCINOMA STAGE IV HEMISENSORY NEGLECT 4
PS LUNG ADENOCARCINOMA STAGE IV ILEUS PARALYTIC 2
PS LUNG ADENOCARCINOMA STAGE IV INSOMNIA 3
PS LUNG ADENOCARCINOMA STAGE IV LUNG DISORDER 2
PS LUNG ADENOCARCINOMA STAGE IV NEOPLASM PROGRESSION 2
PS LUNG ADENOCARCINOMA STAGE IV PERIPHERAL EMBOLISM 1
PS LUNG ADENOCARCINOMA STAGE IV PLATELET COUNT DECREASED 8
PS LUNG ADENOCARCINOMA STAGE IV PNEUMONITIS 1
PS LUNG ADENOCARCINOMA STAGE IV PYELONEPHRITIS 2
PS LUNG ADENOCARCINOMA STAGE IV SEPTIC SHOCK 6
PS LUNG ADENOCARCINOMA STAGE IV TYMPANIC MEMBRANE PERFORATION 2
PS LUNG ADENOCARCINOMA STAGE IV VENOUS THROMBOSIS LIMB 6
PS LUNG CANCER METASTATIC ABDOMINAL PAIN UPPER 2
PS LUNG CANCER METASTATIC CYTOLYTIC HEPATITIS 2
PS LUNG CANCER METASTATIC DEATH 2
PS LUNG CANCER METASTATIC DIARRHOEA 2
PS LUNG CANCER METASTATIC NAUSEA 2
PS LUNG CANCER METASTATIC THROMBOCYTOPENIA 2
PS LUNG CANCER METASTATIC TRANSAMINASES INCREASED 2
PS LUNG CANCER METASTATIC VOMITING 2
PS LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0 DEATH 1
PS LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0 HOSPICE CARE 3
PS LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0 NEOPLASM MALIGNANT 2
PS LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV DEATH 1
PS LUNG NEOPLASM MALIGNANT ABDOMINAL PAIN 1
PS LUNG NEOPLASM MALIGNANT ARTHRALGIA 1
PS LUNG NEOPLASM MALIGNANT CANDIDIASIS 2
PS LUNG NEOPLASM MALIGNANT CONFUSIONAL STATE 1
PS LUNG NEOPLASM MALIGNANT COUGH 1
PS LUNG NEOPLASM MALIGNANT DEATH 2
PS LUNG NEOPLASM MALIGNANT DIARRHOEA 2
PS LUNG NEOPLASM MALIGNANT DIZZINESS 1
PS LUNG NEOPLASM MALIGNANT DIZZINESS POSTURAL 1
PS LUNG NEOPLASM MALIGNANT DYSPHAGIA 1
PS LUNG NEOPLASM MALIGNANT DYSPNOEA 2
PS LUNG NEOPLASM MALIGNANT ESCHERICHIA INFECTION 2
PS LUNG NEOPLASM MALIGNANT FATIGUE 1
PS LUNG NEOPLASM MALIGNANT GASTROINTESTINAL NECROSIS 2
PS LUNG NEOPLASM MALIGNANT GENERAL PHYSICAL HEALTH DETERIORATION 2
PS LUNG NEOPLASM MALIGNANT GENERALISED ERYTHEMA 1
PS LUNG NEOPLASM MALIGNANT HAEMATEMESIS 1
PS LUNG NEOPLASM MALIGNANT HEPATIC CIRRHOSIS 2
PS LUNG NEOPLASM MALIGNANT HEPATORENAL SYNDROME 2
PS LUNG NEOPLASM MALIGNANT HOSPITALISATION 1
PS LUNG NEOPLASM MALIGNANT HYPERKALAEMIA 2
PS LUNG NEOPLASM MALIGNANT INTUSSUSCEPTION 2
PS LUNG NEOPLASM MALIGNANT LUNG DISORDER 2
PS LUNG NEOPLASM MALIGNANT MALAISE 1
PS LUNG NEOPLASM MALIGNANT NAUSEA 2
PS LUNG NEOPLASM MALIGNANT ODYNOPHAGIA 1
PS LUNG NEOPLASM MALIGNANT OLIGURIA 1
PS LUNG NEOPLASM MALIGNANT PAIN IN EXTREMITY 1
PS LUNG NEOPLASM MALIGNANT PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1
PS LUNG NEOPLASM MALIGNANT PANCYTOPENIA 2
PS LUNG NEOPLASM MALIGNANT PULMONARY FIBROSIS 1
PS LUNG NEOPLASM MALIGNANT SYNCOPE 2
PS LUNG NEOPLASM MALIGNANT VOMITING 1
PS LUNG NEOPLASM MALIGNANT WHITE BLOOD CELL COUNT DECREASED 1
PS LYMPHOCYTIC LYMPHOMA BLOOD DISORDER 1
PS LYMPHOCYTIC LYMPHOMA DEAFNESS 1
PS LYMPHOCYTIC LYMPHOMA PYREXIA 1
PS LYMPHOCYTIC LYMPHOMA TINNITUS 1
PS LYMPHOCYTIC LYMPHOMA TOXIC SKIN ERUPTION 1
PS MALIGNANT NEOPLASM OF PLEURA DEATH 1
PS MALIGNANT NEOPLASM OF PLEURA DISEASE COMPLICATION 1
PS MALIGNANT NEOPLASM OF PLEURA NEOPLASM PROGRESSION 1
PS MESOTHELIOMA CARDIOMYOPATHY 1
PS MESOTHELIOMA FLUID OVERLOAD 1
PS MESOTHELIOMA PAPILLOEDEMA 2
PS MESOTHELIOMA THERAPY RESPONDER 2
PS MESOTHELIOMA THROMBOCYTOSIS 2
PS MESOTHELIOMA MALIGNANT BRONCHOSPASM 2
PS MESOTHELIOMA MALIGNANT DYSPNOEA 2
PS MESOTHELIOMA MALIGNANT ERYTHEMA 2
PS MESOTHELIOMA MALIGNANT LOSS OF CONSCIOUSNESS 2
PS MYOCARDIAL ISCHAEMIA CANDIDIASIS 5
PS MYOCARDIAL ISCHAEMIA DIARRHOEA 5
PS MYOCARDIAL ISCHAEMIA ESCHERICHIA INFECTION 5
PS MYOCARDIAL ISCHAEMIA GASTROINTESTINAL NECROSIS 5
PS MYOCARDIAL ISCHAEMIA GENERAL PHYSICAL HEALTH DETERIORATION 5
PS MYOCARDIAL ISCHAEMIA HEPATIC CIRRHOSIS 5
PS MYOCARDIAL ISCHAEMIA HEPATORENAL SYNDROME 5
PS MYOCARDIAL ISCHAEMIA HYPERKALAEMIA 5
PS MYOCARDIAL ISCHAEMIA INTUSSUSCEPTION 5
PS MYOCARDIAL ISCHAEMIA LUNG DISORDER 5
PS MYOCARDIAL ISCHAEMIA PANCYTOPENIA 5
PS NAUSEA DIZZINESS 2
PS NAUSEA DYSPHAGIA 2
PS NAUSEA NAUSEA 2
PS NAUSEA ODYNOPHAGIA 2
PS NEOPLASM CEREBRAL INFARCTION 1
PS NEOPLASM NEOPLASM PROGRESSION 1
PS NEOPLASM MALIGNANT CONFUSIONAL STATE 1
PS NEOPLASM MALIGNANT FATIGUE 1
PS NEOPLASM MALIGNANT SYNCOPE 2
PS NON-SMALL CELL LUNG CANCER ABDOMINAL ABSCESS 2
PS NON-SMALL CELL LUNG CANCER ABDOMINAL PAIN 4
PS NON-SMALL CELL LUNG CANCER ACIDOSIS 2
PS NON-SMALL CELL LUNG CANCER ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1
PS NON-SMALL CELL LUNG CANCER ALANINE AMINOTRANSFERASE INCREASED 1
PS NON-SMALL CELL LUNG CANCER ANAEMIA 2
PS NON-SMALL CELL LUNG CANCER ANAPHYLACTIC REACTION 6
PS NON-SMALL CELL LUNG CANCER APHASIA 2
PS NON-SMALL CELL LUNG CANCER ASPARTATE AMINOTRANSFERASE INCREASED 1
PS NON-SMALL CELL LUNG CANCER ASTHENIA 4
PS NON-SMALL CELL LUNG CANCER ATRIAL FIBRILLATION 4
PS NON-SMALL CELL LUNG CANCER BLOOD PRESSURE DECREASED 6
PS NON-SMALL CELL LUNG CANCER BONE MARROW FAILURE 4
PS NON-SMALL CELL LUNG CANCER CARDIAC ARREST 4
PS NON-SMALL CELL LUNG CANCER CEREBROVASCULAR ACCIDENT 3
PS NON-SMALL CELL LUNG CANCER CHOLESTASIS 3
PS NON-SMALL CELL LUNG CANCER CHRONIC LYMPHOCYTIC LEUKAEMIA 4
PS NON-SMALL CELL LUNG CANCER CLOSTRIDIAL INFECTION 1
PS NON-SMALL CELL LUNG CANCER COAGULOPATHY 2
PS NON-SMALL CELL LUNG CANCER CONSTIPATION 2
PS NON-SMALL CELL LUNG CANCER DECREASED APPETITE 4
PS NON-SMALL CELL LUNG CANCER DIARRHOEA 4
PS NON-SMALL CELL LUNG CANCER DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1
PS NON-SMALL CELL LUNG CANCER DUODENAL ULCER HAEMORRHAGE 2
PS NON-SMALL CELL LUNG CANCER ELECTROLYTE IMBALANCE 4
PS NON-SMALL CELL LUNG CANCER EYELID OEDEMA 6
PS NON-SMALL CELL LUNG CANCER FEBRILE NEUTROPENIA 1
PS NON-SMALL CELL LUNG CANCER GAMMA-GLUTAMYLTRANSFERASE INCREASED 1
PS NON-SMALL CELL LUNG CANCER GASTRIC ULCER HAEMORRHAGE 2
PS NON-SMALL CELL LUNG CANCER GENERAL PHYSICAL HEALTH DETERIORATION 2
PS NON-SMALL CELL LUNG CANCER HAEMATOTOXICITY 2
PS NON-SMALL CELL LUNG CANCER HEMIPARESIS 2
PS NON-SMALL CELL LUNG CANCER HEPATOCELLULAR INJURY 1
PS NON-SMALL CELL LUNG CANCER HOSPITALISATION 2
PS NON-SMALL CELL LUNG CANCER HYPERGLYCAEMIA 2
PS NON-SMALL CELL LUNG CANCER HYPERNATRAEMIA 4
PS NON-SMALL CELL LUNG CANCER HYPOTENSION 2
PS NON-SMALL CELL LUNG CANCER INTERSTITIAL LUNG DISEASE 1
PS NON-SMALL CELL LUNG CANCER LISTLESS 4
PS NON-SMALL CELL LUNG CANCER LUNG INFECTION 4
PS NON-SMALL CELL LUNG CANCER LUNG NEOPLASM SURGERY 2
PS NON-SMALL CELL LUNG CANCER MENTAL DISORDER 1
PS NON-SMALL CELL LUNG CANCER MOUTH ULCERATION 2
PS NON-SMALL CELL LUNG CANCER MULTI-ORGAN FAILURE 1
PS NON-SMALL CELL LUNG CANCER MYOCARDIAL INFARCTION 1
PS NON-SMALL CELL LUNG CANCER NAUSEA 1
PS NON-SMALL CELL LUNG CANCER NEOPLASM PROGRESSION 6
PS NON-SMALL CELL LUNG CANCER NEUTROPENIA 4
PS NON-SMALL CELL LUNG CANCER NEUTROPENIC SEPSIS 1
PS NON-SMALL CELL LUNG CANCER PANCYTOPENIA 9
PS NON-SMALL CELL LUNG CANCER PARAESTHESIA 1
PS NON-SMALL CELL LUNG CANCER PETECHIAE 2
PS NON-SMALL CELL LUNG CANCER PNEUMONITIS 3
PS NON-SMALL CELL LUNG CANCER PROTHROMBIN TIME SHORTENED 2
PS NON-SMALL CELL LUNG CANCER PULMONARY EMBOLISM 2
PS NON-SMALL CELL LUNG CANCER PULMONARY FIBROSIS 1
PS NON-SMALL CELL LUNG CANCER RENAL FAILURE 5
PS NON-SMALL CELL LUNG CANCER RENAL FAILURE ACUTE 2
PS NON-SMALL CELL LUNG CANCER RESPIRATORY FAILURE 3
PS NON-SMALL CELL LUNG CANCER SKIN TOXICITY 2
PS NON-SMALL CELL LUNG CANCER THROMBOCYTOPENIA 6
PS NON-SMALL CELL LUNG CANCER THROMBOTIC MICROANGIOPATHY 2
PS NON-SMALL CELL LUNG CANCER VASCULITIS 1
PS NON-SMALL CELL LUNG CANCER VENTRICULAR ARRHYTHMIA 4
PS NON-SMALL CELL LUNG CANCER VERTIGO POSITIONAL 1
PS NON-SMALL CELL LUNG CANCER VOMITING 1
PS NON-SMALL CELL LUNG CANCER METASTATIC FEBRILE NEUTROPENIA 1
PS NON-SMALL CELL LUNG CANCER METASTATIC MULTI-ORGAN FAILURE 1
PS NON-SMALL CELL LUNG CANCER METASTATIC RENAL FAILURE 1
PS NON-SMALL CELL LUNG CANCER RECURRENT BILIARY TRACT DISORDER 2
PS NON-SMALL CELL LUNG CANCER RECURRENT LUNG DISORDER 2
PS NON-SMALL CELL LUNG CANCER STAGE IV DEATH 1
PS PAIN ASTHENIA 2
PS PAIN CHEST PAIN 2
PS PAIN CHILLS 2
PS PAIN DEHYDRATION 2
PS PAIN DIARRHOEA 2
PS PAIN DIZZINESS 4
PS PAIN DYSPHAGIA 2
PS PAIN ERYTHEMA 2
PS PAIN GENERALISED ERYTHEMA 2
PS PAIN HAEMATEMESIS 2
PS PAIN HYPOPHAGIA 2
PS PAIN HYPOTENSION 4
PS PAIN MALAISE 4
PS PAIN MUCOSAL INFLAMMATION 2
PS PAIN NAUSEA 2
PS PAIN ODYNOPHAGIA 2
PS PAIN OFF LABEL USE 2
PS PAIN PAIN 2
PS PAIN PANCYTOPENIA 2
PS PAIN PRODUCTIVE COUGH 2
PS PAIN SEPSIS 2
PS PAIN SINUS TACHYCARDIA 2
PS PAIN SKIN INJURY 2
PS PAIN TACHYCARDIA 2
PS PAIN IN EXTREMITY ARTERIOSCLEROSIS 1
PS PAIN IN EXTREMITY CORONARY ARTERY STENOSIS 1
PS PAIN IN EXTREMITY METASTASIS 2
PS PAIN IN EXTREMITY MYOCARDIAL INFARCTION 2
PS PAIN MANAGEMENT ALANINE AMINOTRANSFERASE INCREASED 2
PS PAIN MANAGEMENT ASPARTATE AMINOTRANSFERASE INCREASED 2
PS PAIN MANAGEMENT BLOOD ALKALINE PHOSPHATASE INCREASED 2
PS PAIN MANAGEMENT FATIGUE 2
PS PLEURAL MESOTHELIOMA BLOOD DISORDER 3
PS PLEURAL MESOTHELIOMA DEAFNESS 3
PS PLEURAL MESOTHELIOMA DISTURBANCE IN ATTENTION 2
PS PLEURAL MESOTHELIOMA DIZZINESS 2
PS PLEURAL MESOTHELIOMA FALL 2
PS PLEURAL MESOTHELIOMA GASTROINTESTINAL TOXICITY 2
PS PLEURAL MESOTHELIOMA PANCYTOPENIA 2
PS PLEURAL MESOTHELIOMA PYREXIA 3
PS PLEURAL MESOTHELIOMA RHEUMATOID ARTHRITIS 2
PS PLEURAL MESOTHELIOMA TINNITUS 3
PS PLEURAL MESOTHELIOMA TOXIC SKIN ERUPTION 3
PS PLEURAL MESOTHELIOMA MALIGNANT ACUTE PRERENAL FAILURE 8
PS PLEURAL MESOTHELIOMA MALIGNANT ADVERSE REACTION 4
PS PLEURAL MESOTHELIOMA MALIGNANT ARTERIOSCLEROSIS 2
PS PLEURAL MESOTHELIOMA MALIGNANT CHEST PAIN 2
PS PLEURAL MESOTHELIOMA MALIGNANT CORONARY ARTERY STENOSIS 2
PS PLEURAL MESOTHELIOMA MALIGNANT COUGH 2
PS PLEURAL MESOTHELIOMA MALIGNANT INSOMNIA 2
PS PLEURAL MESOTHELIOMA MALIGNANT METASTASES TO BONE 8
PS PLEURAL MESOTHELIOMA MALIGNANT METASTASIS 4
PS PLEURAL MESOTHELIOMA MALIGNANT MYOCARDIAL INFARCTION 5
PS PLEURAL MESOTHELIOMA MALIGNANT NEOPLASM PROGRESSION 10
PS PLEURAL MESOTHELIOMA MALIGNANT NEPHROTIC SYNDROME 10
PS PLEURAL MESOTHELIOMA MALIGNANT OFF LABEL USE 8
PS PLEURAL MESOTHELIOMA MALIGNANT WHITE BLOOD CELL COUNT DECREASED 2
PS PREMEDICATION BLOOD DISORDER 5
PS PREMEDICATION CANDIDIASIS 1
PS PREMEDICATION COUNTERFEIT DRUG ADMINISTERED 6
PS PREMEDICATION DEAFNESS 5
PS PREMEDICATION DIARRHOEA 1
PS PREMEDICATION ESCHERICHIA INFECTION 1
PS PREMEDICATION ESCHERICHIA SEPSIS 3
PS PREMEDICATION ESCHERICHIA TEST POSITIVE 3
PS PREMEDICATION GASTROINTESTINAL NECROSIS 1
PS PREMEDICATION GENERAL PHYSICAL HEALTH DETERIORATION 1
PS PREMEDICATION HEPATIC CIRRHOSIS 1
PS PREMEDICATION HEPATORENAL SYNDROME 1
PS PREMEDICATION HYPERKALAEMIA 1
PS PREMEDICATION HYPOTHYROIDISM 3
PS PREMEDICATION INTUSSUSCEPTION 1
PS PREMEDICATION LUNG DISORDER 1
PS PREMEDICATION PANCYTOPENIA 1
PS PREMEDICATION PYREXIA 5
PS PREMEDICATION TINNITUS 5
PS PREMEDICATION TOXIC SKIN ERUPTION 5
PS PREMEDICATION WHITE BLOOD CELL COUNT DECREASED 6
PS PRODUCTIVE COUGH CHOLECYSTITIS CHRONIC 1
PS PRODUCTIVE COUGH LUNG DISORDER 1
PS PRODUCTIVE COUGH PYELONEPHRITIS 1
PS PROPHYLAXIS ACUTE PRERENAL FAILURE 8
PS PROPHYLAXIS ADVERSE REACTION 4
PS PROPHYLAXIS ALANINE AMINOTRANSFERASE INCREASED 4
PS PROPHYLAXIS ANAEMIA 1
PS PROPHYLAXIS ARTERIOSCLEROSIS 4
PS PROPHYLAXIS ARTHRALGIA 1
PS PROPHYLAXIS ASPARTATE AMINOTRANSFERASE INCREASED 4
PS PROPHYLAXIS BLOOD ALKALINE PHOSPHATASE INCREASED 4
PS PROPHYLAXIS BLOOD IRON INCREASED 2
PS PROPHYLAXIS BONE MARROW FAILURE 2
PS PROPHYLAXIS CHOLECYSTITIS ACUTE 6
PS PROPHYLAXIS CHOLECYSTITIS CHRONIC 1
PS PROPHYLAXIS CHRONIC LYMPHOCYTIC LEUKAEMIA 1
PS PROPHYLAXIS CONFUSIONAL STATE 2
PS PROPHYLAXIS CORONARY ARTERY STENOSIS 4
PS PROPHYLAXIS DELIRIUM 2
PS PROPHYLAXIS DIZZINESS POSTURAL 1
PS PROPHYLAXIS DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1
PS PROPHYLAXIS FATIGUE 4
PS PROPHYLAXIS GENERAL PHYSICAL HEALTH DETERIORATION 1
PS PROPHYLAXIS ILEUS PARALYTIC 3
PS PROPHYLAXIS INSOMNIA 2
PS PROPHYLAXIS INTERSTITIAL LUNG DISEASE 2
PS PROPHYLAXIS LUNG DISORDER 1
PS PROPHYLAXIS METASTASES TO BONE 8
PS PROPHYLAXIS METASTASIS 8
PS PROPHYLAXIS MYOCARDIAL INFARCTION 8
PS PROPHYLAXIS NAUSEA 1
PS PROPHYLAXIS NEOPLASM PROGRESSION 13
PS PROPHYLAXIS NEPHROTIC SYNDROME 10
PS PROPHYLAXIS NEUTROPENIA 1
PS PROPHYLAXIS OFF LABEL USE 8
PS PROPHYLAXIS PARAESTHESIA 1
PS PROPHYLAXIS PERIPHERAL EMBOLISM 1
PS PROPHYLAXIS PETECHIAE 1
PS PROPHYLAXIS PLATELET COUNT DECREASED 6
PS PROPHYLAXIS PNEUMONITIS 1
PS PROPHYLAXIS PYELONEPHRITIS 1
PS PROPHYLAXIS RASH 2
PS PROPHYLAXIS SEPTIC SHOCK 6
PS PROPHYLAXIS THROMBOCYTOPENIA 1
PS PROPHYLAXIS VENOUS THROMBOSIS LIMB 6
PS PROPHYLAXIS VOMITING 1
PS PROPHYLAXIS WHITE BLOOD CELL COUNT DECREASED 2
PS PROPHYLAXIS OF NAUSEA AND VOMITING BLOOD IRON INCREASED 6
PS PROPHYLAXIS OF NAUSEA AND VOMITING BONE MARROW FAILURE 2
PS PROPHYLAXIS OF NAUSEA AND VOMITING CANDIDIASIS 1
PS PROPHYLAXIS OF NAUSEA AND VOMITING CHOLECYSTITIS CHRONIC 1
PS PROPHYLAXIS OF NAUSEA AND VOMITING CONFUSIONAL STATE 6
PS PROPHYLAXIS OF NAUSEA AND VOMITING DELIRIUM 6
PS PROPHYLAXIS OF NAUSEA AND VOMITING DIARRHOEA 1
PS PROPHYLAXIS OF NAUSEA AND VOMITING ESCHERICHIA INFECTION 1
PS PROPHYLAXIS OF NAUSEA AND VOMITING GASTROINTESTINAL NECROSIS 1
PS PROPHYLAXIS OF NAUSEA AND VOMITING GENERAL PHYSICAL HEALTH DETERIORATION 1
PS PROPHYLAXIS OF NAUSEA AND VOMITING HEPATIC CIRRHOSIS 1
PS PROPHYLAXIS OF NAUSEA AND VOMITING HEPATORENAL SYNDROME 1
PS PROPHYLAXIS OF NAUSEA AND VOMITING HYPERKALAEMIA 1
PS PROPHYLAXIS OF NAUSEA AND VOMITING INSOMNIA 6
PS PROPHYLAXIS OF NAUSEA AND VOMITING INTERSTITIAL LUNG DISEASE 2
PS PROPHYLAXIS OF NAUSEA AND VOMITING INTUSSUSCEPTION 1
PS PROPHYLAXIS OF NAUSEA AND VOMITING LUNG DISORDER 2
PS PROPHYLAXIS OF NAUSEA AND VOMITING PANCYTOPENIA 1
PS PROPHYLAXIS OF NAUSEA AND VOMITING PYELONEPHRITIS 1
PS PROPHYLAXIS OF NAUSEA AND VOMITING RASH 2
PS PULMONARY EMBOLISM ATRIAL FIBRILLATION 2
PS PULMONARY EMBOLISM CEREBROVASCULAR ACCIDENT 2
PS PULMONARY EMBOLISM DIARRHOEA 2
PS PULMONARY EMBOLISM DYSARTHRIA 2
PS PULMONARY EMBOLISM HEMIANOPIA 2
PS PULMONARY EMBOLISM HEMIPLEGIA 2
PS PULMONARY EMBOLISM HEMISENSORY NEGLECT 2
PS SUPPLEMENTATION THERAPY ABDOMINAL ABSCESS 2
PS SUPPLEMENTATION THERAPY CANDIDIASIS 1
PS SUPPLEMENTATION THERAPY DIARRHOEA 1
PS SUPPLEMENTATION THERAPY ESCHERICHIA INFECTION 1
PS SUPPLEMENTATION THERAPY GASTRIC ULCER HAEMORRHAGE 2
PS SUPPLEMENTATION THERAPY GASTROINTESTINAL NECROSIS 1
PS SUPPLEMENTATION THERAPY GASTROINTESTINAL TOXICITY 2
PS SUPPLEMENTATION THERAPY GENERAL PHYSICAL HEALTH DETERIORATION 1
PS SUPPLEMENTATION THERAPY HEPATIC CIRRHOSIS 1
PS SUPPLEMENTATION THERAPY HEPATORENAL SYNDROME 1
PS SUPPLEMENTATION THERAPY HYPERKALAEMIA 1
PS SUPPLEMENTATION THERAPY INTUSSUSCEPTION 1
PS SUPPLEMENTATION THERAPY LUNG DISORDER 1
PS SUPPLEMENTATION THERAPY PANCYTOPENIA 3
PS SUPPLEMENTATION THERAPY PULMONARY EMBOLISM 2
PS SUPPLEMENTATION THERAPY THROMBOCYTOPENIA 2
PS THYMOMA DECREASED APPETITE 2
PS THYMOMA DIARRHOEA 2
PS THYMOMA HAEMOPTYSIS 2
PS THYMOMA NEUTROPENIA 2
PS THYMOMA OFF LABEL USE 2
PS THYMOMA SEPSIS 2
PS THYMOMA WEIGHT DECREASED 2
PS VITAMIN SUPPLEMENTATION ANAEMIA 2
PS VITAMIN SUPPLEMENTATION APHASIA 2
PS VITAMIN SUPPLEMENTATION CANDIDIASIS 2
PS VITAMIN SUPPLEMENTATION CEREBROVASCULAR ACCIDENT 2
PS VITAMIN SUPPLEMENTATION CHOLESTASIS 2
PS VITAMIN SUPPLEMENTATION CHRONIC LYMPHOCYTIC LEUKAEMIA 4
PS VITAMIN SUPPLEMENTATION COAGULOPATHY 2
PS VITAMIN SUPPLEMENTATION DIARRHOEA 2
PS VITAMIN SUPPLEMENTATION DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2
PS VITAMIN SUPPLEMENTATION ESCHERICHIA INFECTION 2
PS VITAMIN SUPPLEMENTATION GASTROINTESTINAL NECROSIS 2
PS VITAMIN SUPPLEMENTATION GENERAL PHYSICAL HEALTH DETERIORATION 4
PS VITAMIN SUPPLEMENTATION HAEMATOTOXICITY 2
PS VITAMIN SUPPLEMENTATION HEMIPARESIS 2
PS VITAMIN SUPPLEMENTATION HEPATIC CIRRHOSIS 2
PS VITAMIN SUPPLEMENTATION HEPATORENAL SYNDROME 2
PS VITAMIN SUPPLEMENTATION HYPERKALAEMIA 2
PS VITAMIN SUPPLEMENTATION INTUSSUSCEPTION 2
PS VITAMIN SUPPLEMENTATION LUNG DISORDER 2
PS VITAMIN SUPPLEMENTATION NAUSEA 2
PS VITAMIN SUPPLEMENTATION NEUTROPENIA 4
PS VITAMIN SUPPLEMENTATION PANCYTOPENIA 2
PS VITAMIN SUPPLEMENTATION PARAESTHESIA 2
PS VITAMIN SUPPLEMENTATION PETECHIAE 2
PS VITAMIN SUPPLEMENTATION PROTHROMBIN TIME SHORTENED 2
PS VITAMIN SUPPLEMENTATION RENAL FAILURE ACUTE 2
PS VITAMIN SUPPLEMENTATION SKIN TOXICITY 2
PS VITAMIN SUPPLEMENTATION THROMBOCYTOPENIA 4
PS VITAMIN SUPPLEMENTATION THROMBOTIC MICROANGIOPATHY 2
PS VITAMIN SUPPLEMENTATION VOMITING 2
SS ANXIETY ALANINE AMINOTRANSFERASE INCREASED 2
SS ANXIETY ASPARTATE AMINOTRANSFERASE INCREASED 2
SS ANXIETY ASPIRATION 2
SS ANXIETY BLOOD POTASSIUM DECREASED 1
SS ANXIETY DEHYDRATION 2
SS ANXIETY DIARRHOEA 2
SS ANXIETY DIZZINESS 1
SS ANXIETY FATIGUE 2
SS ANXIETY FEBRILE NEUTROPENIA 1
SS ANXIETY HAEMATOCRIT DECREASED 1
SS ANXIETY HAEMOGLOBIN DECREASED 1
SS ANXIETY HYPOPHAGIA 2
SS ANXIETY HYPOXIA 2
SS ANXIETY MUSCULAR WEAKNESS 2
SS ANXIETY OFF LABEL USE 2
SS ANXIETY SENSATION OF HEAVINESS 1
SS ANXIETY SOMNOLENCE 1
SS ANXIETY TOXICITY TO VARIOUS AGENTS 1
SS ANXIETY VOMITING 2
SS BONE DISORDER FATIGUE 2
SS BONE DISORDER GENERAL PHYSICAL HEALTH DETERIORATION 2
SS BONE DISORDER ORAL CANDIDIASIS 2
SS BRONCHIAL CARCINOMA ABDOMINAL DISCOMFORT 2
SS BRONCHIAL CARCINOMA AGGRESSION 2
SS BRONCHIAL CARCINOMA AKINESIA 3
SS BRONCHIAL CARCINOMA ALOPECIA 2
SS BRONCHIAL CARCINOMA ARTERIOSCLEROSIS CORONARY ARTERY 3
SS BRONCHIAL CARCINOMA BLOOD COUNT ABNORMAL 2
SS BRONCHIAL CARCINOMA BLOOD URIC ACID INCREASED 2
SS BRONCHIAL CARCINOMA COUGH 2
SS BRONCHIAL CARCINOMA DIZZINESS 2
SS BRONCHIAL CARCINOMA DYSPNOEA 2
SS BRONCHIAL CARCINOMA ERYTHEMA 2
SS BRONCHIAL CARCINOMA FATIGUE 2
SS BRONCHIAL CARCINOMA HYPERHIDROSIS 2
SS BRONCHIAL CARCINOMA MUCOSAL INFLAMMATION 3
SS BRONCHIAL CARCINOMA MUSCULAR WEAKNESS 2
SS BRONCHIAL CARCINOMA MYOCARDIAL INFARCTION 3
SS BRONCHIAL CARCINOMA NAUSEA 2
SS BRONCHIAL CARCINOMA NEOPLASM PROGRESSION 2
SS BRONCHIAL CARCINOMA NEUROPATHY PERIPHERAL 2
SS BRONCHIAL CARCINOMA PANCYTOPENIA 3
SS BRONCHIAL CARCINOMA PERICARDIAL EFFUSION 3
SS BRONCHIAL CARCINOMA PLATELET COUNT DECREASED 2
SS BRONCHIAL CARCINOMA PNEUMONIA 2
SS BRONCHIAL CARCINOMA PRURITUS 2
SS BRONCHIAL CARCINOMA PULMONARY FIBROSIS 2
SS BRONCHIAL CARCINOMA PYREXIA 3
SS BRONCHIAL CARCINOMA RED BLOOD CELL COUNT DECREASED 2
SS BRONCHIAL CARCINOMA RENAL FAILURE 2
SS BRONCHIAL CARCINOMA SKIN DISCOLOURATION 2
SS BRONCHIAL CARCINOMA SKIN MASS 2
SS BRONCHIAL CARCINOMA STRESS CARDIOMYOPATHY 3
SS BRONCHIAL CARCINOMA THYROIDECTOMY 3
SS BRONCHIAL CARCINOMA WEIGHT FLUCTUATION 2
SS BRONCHIAL CARCINOMA WHITE BLOOD CELL COUNT DECREASED 2
SS CANCER PAIN BLOOD PRESSURE DECREASED 1
SS CANCER PAIN BLOOD UREA INCREASED 1
SS CANCER PAIN BONE MARROW FAILURE 1
SS CANCER PAIN CHOLECYSTITIS ACUTE 2
SS CANCER PAIN CONTUSION 1
SS CANCER PAIN DISEASE PROGRESSION 1
SS CANCER PAIN EPISTAXIS 1
SS CANCER PAIN FALL 1
SS CANCER PAIN NEUTROPHIL COUNT DECREASED 1
SS CANCER PAIN SEPTIC SHOCK 2
SS CANCER PAIN VENOUS THROMBOSIS LIMB 2
SS CHRONIC OBSTRUCTIVE PULMONARY DISEASE CONFUSIONAL STATE 1
SS CHRONIC OBSTRUCTIVE PULMONARY DISEASE DEHYDRATION 1
SS CHRONIC OBSTRUCTIVE PULMONARY DISEASE INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1
SS CHRONIC OBSTRUCTIVE PULMONARY DISEASE INCORRECT DOSE ADMINISTERED 1
SS CHRONIC OBSTRUCTIVE PULMONARY DISEASE PNEUMONIA 1
SS COUGH C-REACTIVE PROTEIN INCREASED 1
SS COUGH EPISTAXIS 1
SS COUGH HAEMOPTYSIS 1
SS COUGH PLATELET COUNT DECREASED 1
SS COUGH PYREXIA 1
SS DIABETES MELLITUS SUBDURAL HAEMATOMA 1
SS HYPERTENSION CHOLECYSTITIS ACUTE 2
SS HYPERTENSION SEPTIC SHOCK 2
SS HYPERTENSION SUBDURAL HAEMATOMA 2
SS HYPERTENSION VENOUS THROMBOSIS LIMB 2
SS HYPOPHARYNGEAL CANCER NEOPLASM PROGRESSION 1
SS HYPOPHARYNGEAL CANCER OFF LABEL USE 1
SS HYPOPHARYNGEAL CANCER SPINAL CORD COMPRESSION 1
SS LUNG ADENOCARCINOMA ANAEMIA 10
SS LUNG ADENOCARCINOMA ARTERIAL THROMBOSIS LIMB 6
SS LUNG ADENOCARCINOMA ASCITES 2
SS LUNG ADENOCARCINOMA ASTHENIA 2
SS LUNG ADENOCARCINOMA CONSTIPATION 10
SS LUNG ADENOCARCINOMA CONVULSION 2
SS LUNG ADENOCARCINOMA DEHYDRATION 2
SS LUNG ADENOCARCINOMA DIARRHOEA 12
SS LUNG ADENOCARCINOMA DIVERTICULUM INTESTINAL HAEMORRHAGIC 10
SS LUNG ADENOCARCINOMA EXTREMITY NECROSIS 6
SS LUNG ADENOCARCINOMA FAILURE TO THRIVE 2
SS LUNG ADENOCARCINOMA FEBRILE NEUTROPENIA 2
SS LUNG ADENOCARCINOMA GASTROENTERITIS ESCHERICHIA COLI 10
SS LUNG ADENOCARCINOMA HYPERTENSION 10
SS LUNG ADENOCARCINOMA ISCHAEMIC STROKE 4
SS LUNG ADENOCARCINOMA MELAENA 10
SS LUNG ADENOCARCINOMA NAUSEA 10
SS LUNG ADENOCARCINOMA NEOPLASM MALIGNANT 2
SS LUNG ADENOCARCINOMA PALPITATIONS 4
SS LUNG ADENOCARCINOMA PANCYTOPENIA 2
SS LUNG ADENOCARCINOMA PERIODONTITIS 10
SS LUNG ADENOCARCINOMA PLEURAL EFFUSION 2
SS LUNG ADENOCARCINOMA RENAL FAILURE ACUTE 2
SS LUNG ADENOCARCINOMA VOMITING 10
SS LUNG ADENOCARCINOMA METASTATIC C-REACTIVE PROTEIN INCREASED 3
SS LUNG ADENOCARCINOMA METASTATIC CHOLECYSTITIS ACUTE 6
SS LUNG ADENOCARCINOMA METASTATIC CONVULSION 1
SS LUNG ADENOCARCINOMA METASTATIC EPISTAXIS 3
SS LUNG ADENOCARCINOMA METASTATIC HAEMOPTYSIS 3
SS LUNG ADENOCARCINOMA METASTATIC PLATELET COUNT DECREASED 3
SS LUNG ADENOCARCINOMA METASTATIC PYREXIA 3
SS LUNG ADENOCARCINOMA METASTATIC SEPTIC SHOCK 6
SS LUNG ADENOCARCINOMA METASTATIC VENOUS THROMBOSIS LIMB 6
SS LUNG NEOPLASM MALIGNANT ABDOMINAL PAIN UPPER 2
SS LUNG NEOPLASM MALIGNANT FATIGUE 6
SS LUNG NEOPLASM MALIGNANT GENERAL PHYSICAL HEALTH DETERIORATION 6
SS LUNG NEOPLASM MALIGNANT NAUSEA 2
SS LUNG NEOPLASM MALIGNANT NEUTROPENIC SEPSIS 5
SS LUNG NEOPLASM MALIGNANT ORAL CANDIDIASIS 6
SS LUNG NEOPLASM MALIGNANT THROMBOCYTOPENIA 5
SS LYMPHOCYTIC LYMPHOMA BLOOD DISORDER 1
SS LYMPHOCYTIC LYMPHOMA DEAFNESS 1
SS LYMPHOCYTIC LYMPHOMA PYREXIA 1
SS LYMPHOCYTIC LYMPHOMA TINNITUS 1
SS LYMPHOCYTIC LYMPHOMA TOXIC SKIN ERUPTION 1
SS MESOTHELIOMA PAPILLOEDEMA 2
SS MESOTHELIOMA THERAPY RESPONDER 2
SS NAUSEA ALANINE AMINOTRANSFERASE INCREASED 6
SS NAUSEA ASPARTATE AMINOTRANSFERASE INCREASED 6
SS NAUSEA ASPIRATION 6
SS NAUSEA BLOOD POTASSIUM DECREASED 3
SS NAUSEA DEHYDRATION 6
SS NAUSEA DIARRHOEA 6
SS NAUSEA DIZZINESS 3
SS NAUSEA FATIGUE 6
SS NAUSEA FEBRILE NEUTROPENIA 3
SS NAUSEA HAEMATOCRIT DECREASED 3
SS NAUSEA HAEMOGLOBIN DECREASED 3
SS NAUSEA HYPOPHAGIA 6
SS NAUSEA HYPOXIA 6
SS NAUSEA MUSCULAR WEAKNESS 6
SS NAUSEA OFF LABEL USE 6
SS NAUSEA SENSATION OF HEAVINESS 3
SS NAUSEA SOMNOLENCE 3
SS NAUSEA TOXICITY TO VARIOUS AGENTS 3
SS NAUSEA VOMITING 6
SS NON-SMALL CELL LUNG CANCER ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 3
SS NON-SMALL CELL LUNG CANCER ANAEMIA 6
SS NON-SMALL CELL LUNG CANCER ANAPHYLACTIC REACTION 2
SS NON-SMALL CELL LUNG CANCER BLOOD CREATININE INCREASED 2
SS NON-SMALL CELL LUNG CANCER BLOOD PRESSURE DECREASED 1
SS NON-SMALL CELL LUNG CANCER BLOOD UREA INCREASED 1
SS NON-SMALL CELL LUNG CANCER BONE MARROW FAILURE 1
SS NON-SMALL CELL LUNG CANCER CELLULITIS 2
SS NON-SMALL CELL LUNG CANCER CLOSTRIDIAL INFECTION 3
SS NON-SMALL CELL LUNG CANCER CONFUSIONAL STATE 2
SS NON-SMALL CELL LUNG CANCER CONTUSION 1
SS NON-SMALL CELL LUNG CANCER DEATH 3
SS NON-SMALL CELL LUNG CANCER DECREASED APPETITE 6
SS NON-SMALL CELL LUNG CANCER DEHYDRATION 8
SS NON-SMALL CELL LUNG CANCER DIARRHOEA 4
SS NON-SMALL CELL LUNG CANCER DISEASE PROGRESSION 1
SS NON-SMALL CELL LUNG CANCER DYSPHAGIA 2
SS NON-SMALL CELL LUNG CANCER DYSPNOEA 2
SS NON-SMALL CELL LUNG CANCER EPISTAXIS 1
SS NON-SMALL CELL LUNG CANCER FACE OEDEMA 2
SS NON-SMALL CELL LUNG CANCER FALL 1
SS NON-SMALL CELL LUNG CANCER FATIGUE 2
SS NON-SMALL CELL LUNG CANCER GASTRITIS HAEMORRHAGIC 2
SS NON-SMALL CELL LUNG CANCER GENERAL PHYSICAL HEALTH DETERIORATION 2
SS NON-SMALL CELL LUNG CANCER HAEMATOCRIT ABNORMAL 4
SS NON-SMALL CELL LUNG CANCER HAEMOGLOBIN ABNORMAL 4
SS NON-SMALL CELL LUNG CANCER HAEMORRHAGE 2
SS NON-SMALL CELL LUNG CANCER HYPERBILIRUBINAEMIA 2
SS NON-SMALL CELL LUNG CANCER HYPERGLYCAEMIA 2
SS NON-SMALL CELL LUNG CANCER HYPERSENSITIVITY 2
SS NON-SMALL CELL LUNG CANCER HYPOAESTHESIA 4
SS NON-SMALL CELL LUNG CANCER HYPOCALCAEMIA 2
SS NON-SMALL CELL LUNG CANCER HYPOKALAEMIA 2
SS NON-SMALL CELL LUNG CANCER HYPOPHAGIA 4
SS NON-SMALL CELL LUNG CANCER HYPOTENSION 2
SS NON-SMALL CELL LUNG CANCER HYPOTONIA 2
SS NON-SMALL CELL LUNG CANCER INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6
SS NON-SMALL CELL LUNG CANCER INCORRECT DOSE ADMINISTERED 6
SS NON-SMALL CELL LUNG CANCER MEDICATION ERROR 6
SS NON-SMALL CELL LUNG CANCER MENTAL STATUS CHANGES 4
SS NON-SMALL CELL LUNG CANCER MIXED LIVER INJURY 3
SS NON-SMALL CELL LUNG CANCER MUCOSAL INFLAMMATION 2
SS NON-SMALL CELL LUNG CANCER NAUSEA 4
SS NON-SMALL CELL LUNG CANCER NEOPLASM PROGRESSION 3
SS NON-SMALL CELL LUNG CANCER NEUTROPENIC SEPSIS 3
SS NON-SMALL CELL LUNG CANCER NEUTROPHIL COUNT DECREASED 1
SS NON-SMALL CELL LUNG CANCER OESOPHAGEAL ULCER 2
SS NON-SMALL CELL LUNG CANCER PLATELET COUNT DECREASED 4
SS NON-SMALL CELL LUNG CANCER PNEUMONIA 6
SS NON-SMALL CELL LUNG CANCER PRESYNCOPE 2
SS NON-SMALL CELL LUNG CANCER STOMATITIS 4
SS NON-SMALL CELL LUNG CANCER SUBDURAL HAEMATOMA 3
SS NON-SMALL CELL LUNG CANCER THROMBOCYTOPENIA 4
SS NON-SMALL CELL LUNG CANCER VOMITING 4
SS NON-SMALL CELL LUNG CANCER METASTATIC BLOOD PRESSURE DECREASED 2
SS NON-SMALL CELL LUNG CANCER METASTATIC BLOOD UREA INCREASED 2
SS NON-SMALL CELL LUNG CANCER METASTATIC BONE MARROW FAILURE 2
SS NON-SMALL CELL LUNG CANCER METASTATIC CONTUSION 2
SS NON-SMALL CELL LUNG CANCER METASTATIC DISEASE PROGRESSION 2
SS NON-SMALL CELL LUNG CANCER METASTATIC EPISTAXIS 2
SS NON-SMALL CELL LUNG CANCER METASTATIC FALL 2
SS NON-SMALL CELL LUNG CANCER METASTATIC NEUTROPHIL COUNT DECREASED 2
SS NON-SMALL CELL LUNG CANCER STAGE IV ABDOMINAL PAIN UPPER 6
SS NON-SMALL CELL LUNG CANCER STAGE IV ANAEMIA 2
SS NON-SMALL CELL LUNG CANCER STAGE IV BLOOD CREATININE INCREASED 2
SS NON-SMALL CELL LUNG CANCER STAGE IV DEHYDRATION 2
SS NON-SMALL CELL LUNG CANCER STAGE IV DIARRHOEA 2
SS NON-SMALL CELL LUNG CANCER STAGE IV DIZZINESS POSTURAL 3
SS NON-SMALL CELL LUNG CANCER STAGE IV GASTRITIS HAEMORRHAGIC 2
SS NON-SMALL CELL LUNG CANCER STAGE IV HAEMATOCRIT ABNORMAL 2
SS NON-SMALL CELL LUNG CANCER STAGE IV HAEMOGLOBIN ABNORMAL 2
SS NON-SMALL CELL LUNG CANCER STAGE IV HERPES OESOPHAGITIS 6
SS NON-SMALL CELL LUNG CANCER STAGE IV HYPOAESTHESIA 2
SS NON-SMALL CELL LUNG CANCER STAGE IV HYPOPHAGIA 2
SS NON-SMALL CELL LUNG CANCER STAGE IV INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2
SS NON-SMALL CELL LUNG CANCER STAGE IV INCORRECT DOSE ADMINISTERED 2
SS NON-SMALL CELL LUNG CANCER STAGE IV MENTAL STATUS CHANGES 2
SS NON-SMALL CELL LUNG CANCER STAGE IV NAUSEA 2
SS NON-SMALL CELL LUNG CANCER STAGE IV NEOPLASM MALIGNANT 6
SS NON-SMALL CELL LUNG CANCER STAGE IV NEUTROPENIA 6
SS NON-SMALL CELL LUNG CANCER STAGE IV OESOPHAGEAL ULCER 2
SS NON-SMALL CELL LUNG CANCER STAGE IV PANCYTOPENIA 2
SS NON-SMALL CELL LUNG CANCER STAGE IV PNEUMONIA 8
SS NON-SMALL CELL LUNG CANCER STAGE IV RENAL FAILURE ACUTE 2
SS NON-SMALL CELL LUNG CANCER STAGE IV STOMATITIS 2
SS NON-SMALL CELL LUNG CANCER STAGE IV THROMBOCYTOPENIA 2
SS NON-SMALL CELL LUNG CANCER STAGE IV VOMITING 2
SS OROPHARYNGEAL CANCER RECURRENT ALANINE AMINOTRANSFERASE INCREASED 6
SS OROPHARYNGEAL CANCER RECURRENT ASPARTATE AMINOTRANSFERASE INCREASED 6
SS OROPHARYNGEAL CANCER RECURRENT ASPIRATION 6
SS OROPHARYNGEAL CANCER RECURRENT BLOOD POTASSIUM DECREASED 3
SS OROPHARYNGEAL CANCER RECURRENT DEHYDRATION 6
SS OROPHARYNGEAL CANCER RECURRENT DIARRHOEA 6
SS OROPHARYNGEAL CANCER RECURRENT DIZZINESS 3
SS OROPHARYNGEAL CANCER RECURRENT FATIGUE 6
SS OROPHARYNGEAL CANCER RECURRENT FEBRILE NEUTROPENIA 3
SS OROPHARYNGEAL CANCER RECURRENT HAEMATOCRIT DECREASED 3
SS OROPHARYNGEAL CANCER RECURRENT HAEMOGLOBIN DECREASED 3
SS OROPHARYNGEAL CANCER RECURRENT HYPOPHAGIA 6
SS OROPHARYNGEAL CANCER RECURRENT HYPOXIA 6
SS OROPHARYNGEAL CANCER RECURRENT MUSCULAR WEAKNESS 6
SS OROPHARYNGEAL CANCER RECURRENT OFF LABEL USE 6
SS OROPHARYNGEAL CANCER RECURRENT SENSATION OF HEAVINESS 3
SS OROPHARYNGEAL CANCER RECURRENT SOMNOLENCE 3
SS OROPHARYNGEAL CANCER RECURRENT TOXICITY TO VARIOUS AGENTS 3
SS OROPHARYNGEAL CANCER RECURRENT VOMITING 6
SS PAIN ALANINE AMINOTRANSFERASE INCREASED 2
SS PAIN ANAEMIA 2
SS PAIN ASPARTATE AMINOTRANSFERASE INCREASED 2
SS PAIN ASPIRATION 2
SS PAIN BLOOD CREATININE INCREASED 2
SS PAIN BLOOD POTASSIUM DECREASED 1
SS PAIN DECREASED APPETITE 1
SS PAIN DEHYDRATION 5
SS PAIN DIARRHOEA 5
SS PAIN DIZZINESS 1
SS PAIN FATIGUE 3
SS PAIN FEBRILE NEUTROPENIA 1
SS PAIN GASTRITIS HAEMORRHAGIC 2
SS PAIN HAEMATOCRIT ABNORMAL 3
SS PAIN HAEMATOCRIT DECREASED 1
SS PAIN HAEMOGLOBIN ABNORMAL 3
SS PAIN HAEMOGLOBIN DECREASED 1
SS PAIN HYPOAESTHESIA 3
SS PAIN HYPOPHAGIA 5
SS PAIN HYPOXIA 2
SS PAIN INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2
SS PAIN INCORRECT DOSE ADMINISTERED 2
SS PAIN MENTAL STATUS CHANGES 3
SS PAIN MUSCULAR WEAKNESS 2
SS PAIN NAUSEA 3
SS PAIN OESOPHAGEAL ULCER 2
SS PAIN OFF LABEL USE 2
SS PAIN PANCYTOPENIA 1
SS PAIN PNEUMONIA 3
SS PAIN PRESYNCOPE 1
SS PAIN RENAL FAILURE ACUTE 1
SS PAIN SENSATION OF HEAVINESS 1
SS PAIN SOMNOLENCE 1
SS PAIN STOMATITIS 3
SS PAIN SUBDURAL HAEMATOMA 2
SS PAIN THROMBOCYTOPENIA 3
SS PAIN TOXICITY TO VARIOUS AGENTS 1
SS PAIN VOMITING 5
SS PAIN IN EXTREMITY ARTERIOSCLEROSIS 1
SS PAIN IN EXTREMITY CORONARY ARTERY STENOSIS 1
SS PAIN IN EXTREMITY METASTASIS 2
SS PAIN IN EXTREMITY MYOCARDIAL INFARCTION 2
SS PLEURAL MESOTHELIOMA BLOOD DISORDER 3
SS PLEURAL MESOTHELIOMA DEAFNESS 3
SS PLEURAL MESOTHELIOMA PYREXIA 3
SS PLEURAL MESOTHELIOMA TINNITUS 3
SS PLEURAL MESOTHELIOMA TOXIC SKIN ERUPTION 3
SS PLEURAL MESOTHELIOMA MALIGNANT ARTERIOSCLEROSIS 2
SS PLEURAL MESOTHELIOMA MALIGNANT CORONARY ARTERY STENOSIS 2
SS PLEURAL MESOTHELIOMA MALIGNANT METASTASIS 4
SS PLEURAL MESOTHELIOMA MALIGNANT MYOCARDIAL INFARCTION 4
SS PREMEDICATION BLOOD DISORDER 5
SS PREMEDICATION DEAFNESS 5
SS PREMEDICATION PYREXIA 5
SS PREMEDICATION TINNITUS 5
SS PREMEDICATION TOXIC SKIN ERUPTION 5
SS PRODUCT USED FOR UNKNOWN INDICATION ALANINE AMINOTRANSFERASE INCREASED 20
SS PRODUCT USED FOR UNKNOWN INDICATION ANAEMIA 9
SS PRODUCT USED FOR UNKNOWN INDICATION ASPARTATE AMINOTRANSFERASE INCREASED 20
SS PRODUCT USED FOR UNKNOWN INDICATION ASPIRATION 20
SS PRODUCT USED FOR UNKNOWN INDICATION BLOOD CREATININE INCREASED 9
SS PRODUCT USED FOR UNKNOWN INDICATION BLOOD POTASSIUM DECREASED 10
SS PRODUCT USED FOR UNKNOWN INDICATION DEHYDRATION 29
SS PRODUCT USED FOR UNKNOWN INDICATION DIARRHOEA 29
SS PRODUCT USED FOR UNKNOWN INDICATION DIZZINESS 10
SS PRODUCT USED FOR UNKNOWN INDICATION FATIGUE 20
SS PRODUCT USED FOR UNKNOWN INDICATION FEBRILE NEUTROPENIA 10
SS PRODUCT USED FOR UNKNOWN INDICATION GASTRITIS HAEMORRHAGIC 9
SS PRODUCT USED FOR UNKNOWN INDICATION HAEMATOCRIT ABNORMAL 9
SS PRODUCT USED FOR UNKNOWN INDICATION HAEMATOCRIT DECREASED 10
SS PRODUCT USED FOR UNKNOWN INDICATION HAEMOGLOBIN ABNORMAL 9
SS PRODUCT USED FOR UNKNOWN INDICATION HAEMOGLOBIN DECREASED 10
SS PRODUCT USED FOR UNKNOWN INDICATION HYPOAESTHESIA 9
SS PRODUCT USED FOR UNKNOWN INDICATION HYPOPHAGIA 29
SS PRODUCT USED FOR UNKNOWN INDICATION HYPOXIA 20
SS PRODUCT USED FOR UNKNOWN INDICATION INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 9
SS PRODUCT USED FOR UNKNOWN INDICATION INCORRECT DOSE ADMINISTERED 9
SS PRODUCT USED FOR UNKNOWN INDICATION MENTAL STATUS CHANGES 9
SS PRODUCT USED FOR UNKNOWN INDICATION MUSCULAR WEAKNESS 20
SS PRODUCT USED FOR UNKNOWN INDICATION NAUSEA 9
SS PRODUCT USED FOR UNKNOWN INDICATION OESOPHAGEAL ULCER 9
SS PRODUCT USED FOR UNKNOWN INDICATION OFF LABEL USE 20
SS PRODUCT USED FOR UNKNOWN INDICATION PANCYTOPENIA 9
SS PRODUCT USED FOR UNKNOWN INDICATION PNEUMONIA 9
SS PRODUCT USED FOR UNKNOWN INDICATION RENAL FAILURE ACUTE 9
SS PRODUCT USED FOR UNKNOWN INDICATION SENSATION OF HEAVINESS 10
SS PRODUCT USED FOR UNKNOWN INDICATION SOMNOLENCE 10
SS PRODUCT USED FOR UNKNOWN INDICATION STOMATITIS 9
SS PRODUCT USED FOR UNKNOWN INDICATION THROMBOCYTOPENIA 9
SS PRODUCT USED FOR UNKNOWN INDICATION TOXICITY TO VARIOUS AGENTS 10
SS PRODUCT USED FOR UNKNOWN INDICATION VOMITING 29
SS PROPHYLAXIS ARTERIOSCLEROSIS 4
SS PROPHYLAXIS BLOOD PRESSURE DECREASED 1
SS PROPHYLAXIS BLOOD UREA INCREASED 1
SS PROPHYLAXIS BONE MARROW FAILURE 1
SS PROPHYLAXIS CHOLECYSTITIS ACUTE 6
SS PROPHYLAXIS CONTUSION 1
SS PROPHYLAXIS CORONARY ARTERY STENOSIS 4
SS PROPHYLAXIS DECREASED APPETITE 4
SS PROPHYLAXIS DISEASE PROGRESSION 1
SS PROPHYLAXIS EPISTAXIS 1
SS PROPHYLAXIS FALL 1
SS PROPHYLAXIS GENERAL PHYSICAL HEALTH DETERIORATION 4
SS PROPHYLAXIS HYPERSENSITIVITY 4
SS PROPHYLAXIS METASTASIS 8
SS PROPHYLAXIS MYOCARDIAL INFARCTION 8
SS PROPHYLAXIS NEUTROPHIL COUNT DECREASED 1
SS PROPHYLAXIS SEPTIC SHOCK 6
SS PROPHYLAXIS VENOUS THROMBOSIS LIMB 6
SS PROPHYLAXIS OF NAUSEA AND VOMITING ADVERSE EVENT 1
SS PROPHYLAXIS OF NAUSEA AND VOMITING BACK PAIN 1
SS PROPHYLAXIS OF NAUSEA AND VOMITING BLOOD PRESSURE DECREASED 2
SS PROPHYLAXIS OF NAUSEA AND VOMITING BLOOD UREA INCREASED 2
SS PROPHYLAXIS OF NAUSEA AND VOMITING BONE MARROW FAILURE 2
SS PROPHYLAXIS OF NAUSEA AND VOMITING CHEST PAIN 1
SS PROPHYLAXIS OF NAUSEA AND VOMITING CONTUSION 2
SS PROPHYLAXIS OF NAUSEA AND VOMITING DISEASE PROGRESSION 2
SS PROPHYLAXIS OF NAUSEA AND VOMITING DYSPNOEA 1
SS PROPHYLAXIS OF NAUSEA AND VOMITING EPISTAXIS 2
SS PROPHYLAXIS OF NAUSEA AND VOMITING ERYTHEMA 1
SS PROPHYLAXIS OF NAUSEA AND VOMITING FALL 2
SS PROPHYLAXIS OF NAUSEA AND VOMITING NEUTROPHIL COUNT DECREASED 2
SS PROPHYLAXIS OF NAUSEA AND VOMITING UNDERDOSE 1
SS PULMONARY EMBOLISM DECREASED APPETITE 1
SS PULMONARY EMBOLISM FATIGUE 1
SS PULMONARY EMBOLISM PRESYNCOPE 1
SS PULMONARY EMBOLISM SUBDURAL HAEMATOMA 2
SS THYMOMA DECREASED APPETITE 2
SS THYMOMA DIARRHOEA 2
SS THYMOMA HAEMOPTYSIS 2
SS THYMOMA NEUTROPENIA 2
SS THYMOMA OFF LABEL USE 2
SS THYMOMA SEPSIS 2
SS THYMOMA WEIGHT DECREASED 2
C ANAESTHESIA ALANINE AMINOTRANSFERASE INCREASED 12
C ANAESTHESIA ALOPECIA 12
C ANAESTHESIA ASPARTATE AMINOTRANSFERASE INCREASED 12
C ANAESTHESIA CARDIAC MURMUR 12
C ANAESTHESIA CONSTIPATION 12
C ANAESTHESIA FATIGUE 12
C ANAESTHESIA ILEUS 12
C ANAESTHESIA MUSCULOSKELETAL PAIN 12
C ANAESTHESIA PERICARDIAL EFFUSION 12
C ANAESTHESIA PLEURAL EFFUSION 12
C ANAESTHESIA PULMONARY MICROEMBOLI 12
C ANXIETY BRAIN NEOPLASM 1
C ANXIETY CONVULSION 1
C ANXIETY DYSPNOEA 1
C ANXIETY EPILEPSY 1
C ANXIETY LUNG ADENOCARCINOMA METASTATIC 1
C ANXIETY MALAISE 1
C ANXIETY METASTASES TO BONE 1
C ANXIETY METASTASES TO LYMPH NODES 1
C ANXIETY NEUTROPHIL COUNT DECREASED 1
C ANXIETY NON-SMALL CELL LUNG CANCER METASTATIC 1
C ANXIETY THROMBOCYTOPENIA 1
C ANXIETY WHITE BLOOD CELL COUNT DECREASED 1
C BLOOD MAGNESIUM DECREASED ALANINE AMINOTRANSFERASE INCREASED 37
C BLOOD MAGNESIUM DECREASED ALOPECIA 37
C BLOOD MAGNESIUM DECREASED ASPARTATE AMINOTRANSFERASE INCREASED 37
C BLOOD MAGNESIUM DECREASED CARDIAC MURMUR 37
C BLOOD MAGNESIUM DECREASED CONSTIPATION 37
C BLOOD MAGNESIUM DECREASED EMBOLISM ARTERIAL 24
C BLOOD MAGNESIUM DECREASED FATIGUE 37
C BLOOD MAGNESIUM DECREASED ILEUS 37
C BLOOD MAGNESIUM DECREASED MUSCULOSKELETAL PAIN 37
C BLOOD MAGNESIUM DECREASED PERICARDIAL EFFUSION 37
C BLOOD MAGNESIUM DECREASED PLEURAL EFFUSION 37
C BLOOD MAGNESIUM DECREASED PULMONARY EMBOLISM 1
C BLOOD MAGNESIUM DECREASED PULMONARY MICROEMBOLI 12
C DEPRESSION BRAIN NEOPLASM 1
C DEPRESSION CONVULSION 1
C DEPRESSION DYSPNOEA 1
C DEPRESSION EPILEPSY 1
C DEPRESSION LUNG ADENOCARCINOMA METASTATIC 1
C DEPRESSION MALAISE 1
C DEPRESSION METASTASES TO BONE 1
C DEPRESSION METASTASES TO LYMPH NODES 1
C DEPRESSION NEUTROPHIL COUNT DECREASED 1
C DEPRESSION NON-SMALL CELL LUNG CANCER METASTATIC 1
C DEPRESSION THROMBOCYTOPENIA 1
C DEPRESSION WHITE BLOOD CELL COUNT DECREASED 1
C DYSPEPSIA ALANINE AMINOTRANSFERASE INCREASED 37
C DYSPEPSIA ALOPECIA 37
C DYSPEPSIA ASPARTATE AMINOTRANSFERASE INCREASED 37
C DYSPEPSIA CARDIAC MURMUR 37
C DYSPEPSIA CONSTIPATION 37
C DYSPEPSIA EMBOLISM ARTERIAL 24
C DYSPEPSIA FATIGUE 37
C DYSPEPSIA ILEUS 37
C DYSPEPSIA MUSCULOSKELETAL PAIN 37
C DYSPEPSIA PERICARDIAL EFFUSION 37
C DYSPEPSIA PLEURAL EFFUSION 37
C DYSPEPSIA PULMONARY EMBOLISM 1
C DYSPEPSIA PULMONARY MICROEMBOLI 12
C HYPERSENSITIVITY ALANINE AMINOTRANSFERASE INCREASED 37
C HYPERSENSITIVITY ALOPECIA 37
C HYPERSENSITIVITY ASPARTATE AMINOTRANSFERASE INCREASED 37
C HYPERSENSITIVITY CARDIAC MURMUR 37
C HYPERSENSITIVITY CONSTIPATION 37
C HYPERSENSITIVITY EMBOLISM ARTERIAL 24
C HYPERSENSITIVITY FATIGUE 37
C HYPERSENSITIVITY ILEUS 37
C HYPERSENSITIVITY MUSCULOSKELETAL PAIN 37
C HYPERSENSITIVITY PERICARDIAL EFFUSION 37
C HYPERSENSITIVITY PLEURAL EFFUSION 37
C HYPERSENSITIVITY PULMONARY EMBOLISM 1
C HYPERSENSITIVITY PULMONARY MICROEMBOLI 12
C LOCAL ANAESTHESIA ALANINE AMINOTRANSFERASE INCREASED 25
C LOCAL ANAESTHESIA ALOPECIA 25
C LOCAL ANAESTHESIA ASPARTATE AMINOTRANSFERASE INCREASED 25
C LOCAL ANAESTHESIA CARDIAC MURMUR 25
C LOCAL ANAESTHESIA CONSTIPATION 25
C LOCAL ANAESTHESIA EMBOLISM ARTERIAL 24
C LOCAL ANAESTHESIA FATIGUE 25
C LOCAL ANAESTHESIA ILEUS 25
C LOCAL ANAESTHESIA MUSCULOSKELETAL PAIN 25
C LOCAL ANAESTHESIA PERICARDIAL EFFUSION 25
C LOCAL ANAESTHESIA PLEURAL EFFUSION 25
C LOCAL ANAESTHESIA PULMONARY EMBOLISM 1
C LUNG ADENOCARCINOMA OMENTAL INFARCTION 6
C LUNG ADENOCARCINOMA METASTATIC DISEASE PROGRESSION 6
C LUNG ADENOCARCINOMA METASTATIC MYOCARDIAL INFARCTION 6
C LUNG ADENOCARCINOMA METASTATIC PLATELET COUNT DECREASED 6
C LUNG ADENOCARCINOMA METASTATIC SUDDEN DEATH 6
C LUNG NEOPLASM MALIGNANT BURNING SENSATION 1
C LUNG NEOPLASM MALIGNANT OEDEMA PERIPHERAL 1
C LUNG NEOPLASM MALIGNANT OSTEONECROSIS 4
C LUNG NEOPLASM MALIGNANT PAIN IN EXTREMITY 1
C LUNG NEOPLASM MALIGNANT SKIN EXFOLIATION 1
C MESOTHELIOMA CARDIAC ARREST 1
C MESOTHELIOMA DYSPNOEA 1
C MESOTHELIOMA LOSS OF CONSCIOUSNESS 1
C METASTASES TO BONE ABDOMINAL PAIN 5
C METASTASES TO BONE ALOPECIA 4
C METASTASES TO BONE ANAEMIA 5
C METASTASES TO BONE ANHEDONIA 5
C METASTASES TO BONE ANXIETY 5
C METASTASES TO BONE ARTERIOSCLEROSIS 4
C METASTASES TO BONE ARTHRALGIA 5
C METASTASES TO BONE ASCITES 4
C METASTASES TO BONE ATELECTASIS 4
C METASTASES TO BONE BACK PAIN 4
C METASTASES TO BONE BLOOD ERYTHROPOIETIN INCREASED 1
C METASTASES TO BONE BLOOD PRESSURE DECREASED 1
C METASTASES TO BONE BLOOD URINE PRESENT 4
C METASTASES TO BONE BONE EROSION 4
C METASTASES TO BONE BONE LOSS 1
C METASTASES TO BONE BONE PAIN 1
C METASTASES TO BONE BRAIN NEOPLASM 1
C METASTASES TO BONE BREAST CANCER METASTATIC 1
C METASTASES TO BONE BULLOUS LUNG DISEASE 4
C METASTASES TO BONE BURNING SENSATION 1
C METASTASES TO BONE CARDIAC TAMPONADE 4
C METASTASES TO BONE CONSTIPATION 4
C METASTASES TO BONE CONVULSION 1
C METASTASES TO BONE CORONARY ARTERY DISEASE 4
C METASTASES TO BONE COUGH 1
C METASTASES TO BONE DENTAL CARIES 4
C METASTASES TO BONE DEPRESSION 4
C METASTASES TO BONE DIVERTICULUM INTESTINAL 4
C METASTASES TO BONE DIZZINESS 1
C METASTASES TO BONE DRUG HYPERSENSITIVITY 1
C METASTASES TO BONE DYSPEPSIA 1
C METASTASES TO BONE DYSPHAGIA 4
C METASTASES TO BONE DYSPNOEA 2
C METASTASES TO BONE DYSPNOEA EXERTIONAL 1
C METASTASES TO BONE DYSURIA 1
C METASTASES TO BONE EMPHYSEMA 5
C METASTASES TO BONE EPILEPSY 1
C METASTASES TO BONE EPISTAXIS 4
C METASTASES TO BONE EXPOSED BONE IN JAW 5
C METASTASES TO BONE FALL 4
C METASTASES TO BONE FATIGUE 1
C METASTASES TO BONE FEMUR FRACTURE 4
C METASTASES TO BONE FIBULA FRACTURE 3
C METASTASES TO BONE GAIT DISTURBANCE 3
C METASTASES TO BONE GASTROENTERITIS RADIATION 4
C METASTASES TO BONE GASTROENTERITIS VIRAL 1
C METASTASES TO BONE GROIN PAIN 4
C METASTASES TO BONE HAEMATURIA 4
C METASTASES TO BONE HAEMOGLOBIN DECREASED 1
C METASTASES TO BONE HAND FRACTURE 1
C METASTASES TO BONE HEPATIC CYST 1
C METASTASES TO BONE HEPATIC MASS 1
C METASTASES TO BONE HILAR LYMPHADENOPATHY 1
C METASTASES TO BONE HYDROCELE 4
C METASTASES TO BONE HYDRONEPHROSIS 4
C METASTASES TO BONE HYDROURETER 4
C METASTASES TO BONE HYPOACUSIS 1
C METASTASES TO BONE HYPOAESTHESIA 5
C METASTASES TO BONE HYPOCALCAEMIA 1
C METASTASES TO BONE IMPAIRED HEALING 4
C METASTASES TO BONE INCORRECT ROUTE OF DRUG ADMINISTRATION 1
C METASTASES TO BONE INGROWING NAIL 4
C METASTASES TO BONE INGUINAL HERNIA 4
C METASTASES TO BONE INGUINAL MASS 1
C METASTASES TO BONE INJURY 5
C METASTASES TO BONE INSOMNIA 4
C METASTASES TO BONE INTERVERTEBRAL DISC PROTRUSION 1
C METASTASES TO BONE JAW FRACTURE 4
C METASTASES TO BONE LEUKOPENIA 4
C METASTASES TO BONE LUNG ADENOCARCINOMA METASTATIC 1
C METASTASES TO BONE LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 1
C METASTASES TO BONE LYMPHADENITIS 1
C METASTASES TO BONE LYMPHADENOPATHY 1
C METASTASES TO BONE LYMPHOEDEMA 4
C METASTASES TO BONE MALAISE 1
C METASTASES TO BONE MASS 1
C METASTASES TO BONE METASTASES TO BONE 3
C METASTASES TO BONE METASTASES TO CENTRAL NERVOUS SYSTEM 1
C METASTASES TO BONE METASTASES TO LIVER 2
C METASTASES TO BONE METASTASES TO LUNG 1
C METASTASES TO BONE METASTASES TO LYMPH NODES 1
C METASTASES TO BONE METASTASES TO SPINE 1
C METASTASES TO BONE NAUSEA 5
C METASTASES TO BONE NECK PAIN 4
C METASTASES TO BONE NEOPLASM MALIGNANT 1
C METASTASES TO BONE NEPHROLITHIASIS 4
C METASTASES TO BONE NEUROPATHY PERIPHERAL 5
C METASTASES TO BONE NEUTROPHIL COUNT DECREASED 1
C METASTASES TO BONE NON-SMALL CELL LUNG CANCER METASTATIC 2
C METASTASES TO BONE OEDEMA PERIPHERAL 2
C METASTASES TO BONE ORAL CAVITY FISTULA 1
C METASTASES TO BONE ORAL INFECTION 1
C METASTASES TO BONE OSTEOLYSIS 1
C METASTASES TO BONE OSTEOMYELITIS 1
C METASTASES TO BONE OSTEONECROSIS OF JAW 5
C METASTASES TO BONE OSTEOPENIA 1
C METASTASES TO BONE OSTEOPOROSIS 1
C METASTASES TO BONE PAIN 5
C METASTASES TO BONE PAIN IN EXTREMITY 5
C METASTASES TO BONE PANCYTOPENIA 5
C METASTASES TO BONE PARONYCHIA 4
C METASTASES TO BONE PATELLA FRACTURE 1
C METASTASES TO BONE PENILE INFECTION 4
C METASTASES TO BONE PERIODONTAL DISEASE 1
C METASTASES TO BONE PERIODONTITIS 3
C METASTASES TO BONE PERIPHERAL VASCULAR DISORDER 3
C METASTASES TO BONE PLEURAL EFFUSION 1
C METASTASES TO BONE PNEUMOTHORAX 1
C METASTASES TO BONE PROSTATE CANCER METASTATIC 4
C METASTASES TO BONE PROSTATOMEGALY 4
C METASTASES TO BONE PULMONARY MASS 1
C METASTASES TO BONE RADICULOPATHY 5
C METASTASES TO BONE RED BLOOD CELL COUNT DECREASED 1
C METASTASES TO BONE RENAL COLIC 4
C METASTASES TO BONE RENAL FAILURE 4
C METASTASES TO BONE RENAL FAILURE ACUTE 1
C METASTASES TO BONE RHINITIS ALLERGIC 1
C METASTASES TO BONE ROTATOR CUFF SYNDROME 3
C METASTASES TO BONE SEPSIS 3
C METASTASES TO BONE SERUM FERRITIN INCREASED 1
C METASTASES TO BONE SKIN EXFOLIATION 1
C METASTASES TO BONE SPINAL OSTEOARTHRITIS 1
C METASTASES TO BONE SPLEEN DISORDER 4
C METASTASES TO BONE STOMATITIS 1
C METASTASES TO BONE SWELLING 4
C METASTASES TO BONE TESTICULAR PAIN 4
C METASTASES TO BONE THROMBOCYTOPENIA 1
C METASTASES TO BONE TOOTH ABSCESS 5
C METASTASES TO BONE TOOTH LOSS 4
C METASTASES TO BONE URETERAL NEOPLASM 4
C METASTASES TO BONE URETHRAL OBSTRUCTION 4
C METASTASES TO BONE UTERINE LEIOMYOMA 1
C METASTASES TO BONE UTERINE MASS 4
C METASTASES TO BONE VITAMIN B12 INCREASED 1
C METASTASES TO BONE VOMITING 5
C METASTASES TO BONE WHITE BLOOD CELL COUNT DECREASED 2
C METASTASES TO CENTRAL NERVOUS SYSTEM ALANINE AMINOTRANSFERASE INCREASED 24
C METASTASES TO CENTRAL NERVOUS SYSTEM ALOPECIA 24
C METASTASES TO CENTRAL NERVOUS SYSTEM ASPARTATE AMINOTRANSFERASE INCREASED 24
C METASTASES TO CENTRAL NERVOUS SYSTEM CARDIAC MURMUR 24
C METASTASES TO CENTRAL NERVOUS SYSTEM CONSTIPATION 24
C METASTASES TO CENTRAL NERVOUS SYSTEM EMBOLISM ARTERIAL 24
C METASTASES TO CENTRAL NERVOUS SYSTEM FATIGUE 24
C METASTASES TO CENTRAL NERVOUS SYSTEM ILEUS 24
C METASTASES TO CENTRAL NERVOUS SYSTEM MUSCULOSKELETAL PAIN 24
C METASTASES TO CENTRAL NERVOUS SYSTEM PERICARDIAL EFFUSION 24
C METASTASES TO CENTRAL NERVOUS SYSTEM PLEURAL EFFUSION 24
C MINERAL SUPPLEMENTATION ALANINE AMINOTRANSFERASE INCREASED 25
C MINERAL SUPPLEMENTATION ALOPECIA 25
C MINERAL SUPPLEMENTATION ASPARTATE AMINOTRANSFERASE INCREASED 25
C MINERAL SUPPLEMENTATION CARDIAC MURMUR 25
C MINERAL SUPPLEMENTATION CONSTIPATION 25
C MINERAL SUPPLEMENTATION EMBOLISM ARTERIAL 24
C MINERAL SUPPLEMENTATION FATIGUE 25
C MINERAL SUPPLEMENTATION ILEUS 25
C MINERAL SUPPLEMENTATION MUSCULOSKELETAL PAIN 25
C MINERAL SUPPLEMENTATION PERICARDIAL EFFUSION 25
C MINERAL SUPPLEMENTATION PLEURAL EFFUSION 25
C MINERAL SUPPLEMENTATION PULMONARY EMBOLISM 1
C MULTIPLE MYELOMA ABDOMINAL PAIN 4
C MULTIPLE MYELOMA ALOPECIA 4
C MULTIPLE MYELOMA ANAEMIA 4
C MULTIPLE MYELOMA ANHEDONIA 4
C MULTIPLE MYELOMA ANXIETY 4
C MULTIPLE MYELOMA ARTERIOSCLEROSIS 4
C MULTIPLE MYELOMA ARTHRALGIA 4
C MULTIPLE MYELOMA ASCITES 4
C MULTIPLE MYELOMA ATELECTASIS 4
C MULTIPLE MYELOMA BACK PAIN 4
C MULTIPLE MYELOMA BLOOD URINE PRESENT 4
C MULTIPLE MYELOMA BONE EROSION 4
C MULTIPLE MYELOMA BULLOUS LUNG DISEASE 4
C MULTIPLE MYELOMA CARDIAC TAMPONADE 4
C MULTIPLE MYELOMA CONSTIPATION 4
C MULTIPLE MYELOMA CORONARY ARTERY DISEASE 4
C MULTIPLE MYELOMA COUGH 1
C MULTIPLE MYELOMA DENTAL CARIES 4
C MULTIPLE MYELOMA DEPRESSION 4
C MULTIPLE MYELOMA DIVERTICULUM INTESTINAL 4
C MULTIPLE MYELOMA DYSPEPSIA 1
C MULTIPLE MYELOMA DYSPHAGIA 3
C MULTIPLE MYELOMA DYSPNOEA 1
C MULTIPLE MYELOMA DYSURIA 1
C MULTIPLE MYELOMA EMPHYSEMA 4
C MULTIPLE MYELOMA EPISTAXIS 4
C MULTIPLE MYELOMA EXPOSED BONE IN JAW 4
C MULTIPLE MYELOMA FALL 4
C MULTIPLE MYELOMA FEMUR FRACTURE 4
C MULTIPLE MYELOMA FIBULA FRACTURE 3
C MULTIPLE MYELOMA GAIT DISTURBANCE 3
C MULTIPLE MYELOMA GASTROENTERITIS RADIATION 4
C MULTIPLE MYELOMA GROIN PAIN 4
C MULTIPLE MYELOMA HAEMATURIA 4
C MULTIPLE MYELOMA HAND FRACTURE 1
C MULTIPLE MYELOMA HEPATIC MASS 1
C MULTIPLE MYELOMA HILAR LYMPHADENOPATHY 1
C MULTIPLE MYELOMA HYDROCELE 4
C MULTIPLE MYELOMA HYDRONEPHROSIS 4
C MULTIPLE MYELOMA HYDROURETER 4
C MULTIPLE MYELOMA HYPOACUSIS 1
C MULTIPLE MYELOMA HYPOAESTHESIA 4
C MULTIPLE MYELOMA IMPAIRED HEALING 4
C MULTIPLE MYELOMA INGROWING NAIL 4
C MULTIPLE MYELOMA INGUINAL HERNIA 4
C MULTIPLE MYELOMA INJURY 4
C MULTIPLE MYELOMA INSOMNIA 4
C MULTIPLE MYELOMA JAW FRACTURE 4
C MULTIPLE MYELOMA LEUKOPENIA 4
C MULTIPLE MYELOMA LYMPHOEDEMA 4
C MULTIPLE MYELOMA METASTASES TO BONE 1
C MULTIPLE MYELOMA METASTASES TO CENTRAL NERVOUS SYSTEM 1
C MULTIPLE MYELOMA METASTASES TO LIVER 1
C MULTIPLE MYELOMA METASTASES TO SPINE 1
C MULTIPLE MYELOMA NAUSEA 4
C MULTIPLE MYELOMA NECK PAIN 4
C MULTIPLE MYELOMA NEPHROLITHIASIS 4
C MULTIPLE MYELOMA NEUROPATHY PERIPHERAL 4
C MULTIPLE MYELOMA NON-SMALL CELL LUNG CANCER METASTATIC 1
C MULTIPLE MYELOMA OSTEONECROSIS OF JAW 4
C MULTIPLE MYELOMA PAIN 4
C MULTIPLE MYELOMA PAIN IN EXTREMITY 4
C MULTIPLE MYELOMA PANCYTOPENIA 4
C MULTIPLE MYELOMA PARONYCHIA 4
C MULTIPLE MYELOMA PENILE INFECTION 4
C MULTIPLE MYELOMA PERIODONTITIS 3
C MULTIPLE MYELOMA PERIPHERAL VASCULAR DISORDER 3
C MULTIPLE MYELOMA PNEUMOTHORAX 1
C MULTIPLE MYELOMA PROSTATE CANCER METASTATIC 4
C MULTIPLE MYELOMA PROSTATOMEGALY 4
C MULTIPLE MYELOMA PULMONARY MASS 1
C MULTIPLE MYELOMA RADICULOPATHY 4
C MULTIPLE MYELOMA RENAL COLIC 4
C MULTIPLE MYELOMA RENAL FAILURE 4
C MULTIPLE MYELOMA ROTATOR CUFF SYNDROME 3
C MULTIPLE MYELOMA SEPSIS 3
C MULTIPLE MYELOMA SPLEEN DISORDER 4
C MULTIPLE MYELOMA SWELLING 4
C MULTIPLE MYELOMA TESTICULAR PAIN 4
C MULTIPLE MYELOMA TOOTH ABSCESS 4
C MULTIPLE MYELOMA TOOTH LOSS 3
C MULTIPLE MYELOMA URETERAL NEOPLASM 4
C MULTIPLE MYELOMA URETHRAL OBSTRUCTION 4
C MULTIPLE MYELOMA UTERINE MASS 4
C MULTIPLE MYELOMA VOMITING 4
C NAUSEA ALANINE AMINOTRANSFERASE INCREASED 74
C NAUSEA ALOPECIA 74
C NAUSEA ASPARTATE AMINOTRANSFERASE INCREASED 74
C NAUSEA CARDIAC MURMUR 74
C NAUSEA CONSTIPATION 74
C NAUSEA EMBOLISM ARTERIAL 48
C NAUSEA FATIGUE 74
C NAUSEA ILEUS 74
C NAUSEA MUSCULOSKELETAL PAIN 74
C NAUSEA PERICARDIAL EFFUSION 74
C NAUSEA PLEURAL EFFUSION 74
C NAUSEA PULMONARY EMBOLISM 2
C NAUSEA PULMONARY MICROEMBOLI 24
C NON-SMALL CELL LUNG CANCER ALANINE AMINOTRANSFERASE INCREASED 148
C NON-SMALL CELL LUNG CANCER ALOPECIA 148
C NON-SMALL CELL LUNG CANCER ASPARTATE AMINOTRANSFERASE INCREASED 148
C NON-SMALL CELL LUNG CANCER BRAIN NEOPLASM 1
C NON-SMALL CELL LUNG CANCER CARDIAC MURMUR 148
C NON-SMALL CELL LUNG CANCER CONSTIPATION 148
C NON-SMALL CELL LUNG CANCER CONVULSION 1
C NON-SMALL CELL LUNG CANCER DEATH 1
C NON-SMALL CELL LUNG CANCER DYSPNOEA 1
C NON-SMALL CELL LUNG CANCER EMBOLISM ARTERIAL 96
C NON-SMALL CELL LUNG CANCER EPILEPSY 1
C NON-SMALL CELL LUNG CANCER FATIGUE 148
C NON-SMALL CELL LUNG CANCER ILEUS 148
C NON-SMALL CELL LUNG CANCER LUNG ADENOCARCINOMA METASTATIC 1
C NON-SMALL CELL LUNG CANCER MALAISE 1
C NON-SMALL CELL LUNG CANCER METASTASES TO BONE 1
C NON-SMALL CELL LUNG CANCER METASTASES TO LYMPH NODES 1
C NON-SMALL CELL LUNG CANCER MUSCULOSKELETAL PAIN 148
C NON-SMALL CELL LUNG CANCER NEUTROPHIL COUNT DECREASED 1
C NON-SMALL CELL LUNG CANCER NON-SMALL CELL LUNG CANCER METASTATIC 1
C NON-SMALL CELL LUNG CANCER PERICARDIAL EFFUSION 148
C NON-SMALL CELL LUNG CANCER PERIPHERAL VASCULAR DISORDER 1
C NON-SMALL CELL LUNG CANCER PLEURAL EFFUSION 148
C NON-SMALL CELL LUNG CANCER PULMONARY EMBOLISM 4
C NON-SMALL CELL LUNG CANCER PULMONARY MICROEMBOLI 48
C NON-SMALL CELL LUNG CANCER SUDDEN DEATH 1
C NON-SMALL CELL LUNG CANCER THROMBOCYTOPENIA 1
C NON-SMALL CELL LUNG CANCER WHITE BLOOD CELL COUNT DECREASED 1
C NON-SMALL CELL LUNG CANCER METASTATIC OSTEONECROSIS 2
C PAIN ALANINE AMINOTRANSFERASE INCREASED 37
C PAIN ALOPECIA 37
C PAIN ASPARTATE AMINOTRANSFERASE INCREASED 37
C PAIN CARDIAC MURMUR 37
C PAIN CONSTIPATION 37
C PAIN EMBOLISM ARTERIAL 24
C PAIN FATIGUE 37
C PAIN ILEUS 37
C PAIN MUSCULOSKELETAL PAIN 37
C PAIN PERICARDIAL EFFUSION 37
C PAIN PLEURAL EFFUSION 37
C PAIN PULMONARY EMBOLISM 1
C PAIN PULMONARY MICROEMBOLI 12
C PRODUCT USED FOR UNKNOWN INDICATION ALANINE AMINOTRANSFERASE INCREASED 406
C PRODUCT USED FOR UNKNOWN INDICATION ALOPECIA 406
C PRODUCT USED FOR UNKNOWN INDICATION ASPARTATE AMINOTRANSFERASE INCREASED 406
C PRODUCT USED FOR UNKNOWN INDICATION CARDIAC MURMUR 406
C PRODUCT USED FOR UNKNOWN INDICATION CONSTIPATION 406
C PRODUCT USED FOR UNKNOWN INDICATION DEATH 1
C PRODUCT USED FOR UNKNOWN INDICATION EMBOLISM ARTERIAL 252
C PRODUCT USED FOR UNKNOWN INDICATION FATIGUE 406
C PRODUCT USED FOR UNKNOWN INDICATION HYPOCALCAEMIA 2
C PRODUCT USED FOR UNKNOWN INDICATION ILEUS 406
C PRODUCT USED FOR UNKNOWN INDICATION INCORRECT ROUTE OF DRUG ADMINISTRATION 2
C PRODUCT USED FOR UNKNOWN INDICATION MUSCULOSKELETAL PAIN 406
C PRODUCT USED FOR UNKNOWN INDICATION PANCYTOPENIA 2
C PRODUCT USED FOR UNKNOWN INDICATION PERICARDIAL EFFUSION 406
C PRODUCT USED FOR UNKNOWN INDICATION PLEURAL EFFUSION 406
C PRODUCT USED FOR UNKNOWN INDICATION PULMONARY EMBOLISM 10
C PRODUCT USED FOR UNKNOWN INDICATION PULMONARY MICROEMBOLI 144
C PRODUCT USED FOR UNKNOWN INDICATION RENAL FAILURE ACUTE 2
C PROPHYLAXIS OF NAUSEA AND VOMITING BACK PAIN 2
C PROPHYLAXIS OF NAUSEA AND VOMITING CHEST PAIN 2
C PROPHYLAXIS OF NAUSEA AND VOMITING DYSPNOEA 2
C PROPHYLAXIS OF NAUSEA AND VOMITING ERYTHEMA 2
C PROPHYLAXIS OF NAUSEA AND VOMITING UNDERDOSE 2
C PROSTATE CANCER CONDITION AGGRAVATED 5
C PROSTATE CANCER JAW FRACTURE 5
C PROSTATE CANCER OSTEONECROSIS OF JAW 5
C PROSTATE CANCER PAIN IN JAW 5
C PROSTATE CANCER SWELLING FACE 5
C SCHIZOPHRENIA BRAIN NEOPLASM 1
C SCHIZOPHRENIA CONVULSION 1
C SCHIZOPHRENIA DYSPNOEA 1
C SCHIZOPHRENIA EPILEPSY 1
C SCHIZOPHRENIA LUNG ADENOCARCINOMA METASTATIC 1
C SCHIZOPHRENIA MALAISE 1
C SCHIZOPHRENIA METASTASES TO BONE 1
C SCHIZOPHRENIA METASTASES TO LYMPH NODES 1
C SCHIZOPHRENIA NEUTROPHIL COUNT DECREASED 1
C SCHIZOPHRENIA NON-SMALL CELL LUNG CANCER METASTATIC 1
C SCHIZOPHRENIA THROMBOCYTOPENIA 1
C SCHIZOPHRENIA WHITE BLOOD CELL COUNT DECREASED 1
C VOMITING ALANINE AMINOTRANSFERASE INCREASED 50
C VOMITING ALOPECIA 50
C VOMITING ASPARTATE AMINOTRANSFERASE INCREASED 50
C VOMITING CARDIAC MURMUR 50
C VOMITING CONSTIPATION 50
C VOMITING EMBOLISM ARTERIAL 48
C VOMITING FATIGUE 50
C VOMITING ILEUS 50
C VOMITING MUSCULOSKELETAL PAIN 50
C VOMITING PERICARDIAL EFFUSION 50
C VOMITING PLEURAL EFFUSION 50
C VOMITING PULMONARY EMBOLISM 2
Ads by Google